神经增强
神经增强（英语：Neuroenhancement）或认知增强（英语：cognitive enhancement），是指对已知无任何精神疾病的健康人身上，通过应用神经生物学研究成果，有针对性地增强或扩展其认知与情感能力，算是个概括性的术语。[1][2][3][4][5][6][7]通过药物或非药物方法来改善神经功能，或是超出了维持或恢复健康所必需的范围，而旨在改善人类形态或机能的干预措施，以及伴随这些目标和做法的神经伦理学讨论。[8][9]
尽管广义上的认知增强剂，还包括使用被认为不健康或有严重副作用的精神活性物质，但神经增强剂仍能几乎不会产生副作用的可靠地为健康人带来超出正常功能的大量认知、社交、心理、情绪或运动方面的益处。[9][7]促智药包括莫达非尼[13]、假马齿苋[19]、磷脂酰丝氨酸[6]和咖啡因[27]等已被证实有健脑功效的药物，与用于治疗神经系统疾病的其他药物。
通过非药物措施来改善认知能力的方法，包括行为方法[28]（活动、技巧和改变）、非侵入性脑刺激技术（已被用于改善各种认知和情感功能）和脑机接口（在扩展运动和认知能力方面具有很大潜力）。[29]
方法
药物方法
有许多包括智能药物与膳食补充剂在内的促智药，与神经或认知增强有关，但许多营养剂在健康人身上起效小，副作用大。最常见、最流行[31][32]或最起效最显著的神经增强剂包括莫达菲尼和哌醋甲酯（利他林），此类药或可能产生显著的促智效果（或至少与咖啡因效果相同或相似）。[33][12][9][9]
一般的兴奋剂[20][22]和各种抗失智药[20][22][34][35]、抗焦虑药[34]、神入感激发剂[36]、各种微量用剂（主要用微剂量迷幻剂）[36][37][38][39]、及抗抑郁药[20][22]，尽管或不被认为是属促智药之范围，但或从属于神经增强的范畴。
尽管神经增强剂通常是在临床或技术领域取得成功后才被考虑投入使用，但其也常被用于帮助缺乏如社交技能与共情能力在内的，正常认知、运动和情感能力的个体。此种情况下，神经增强药物试图增加催产素，降低皮质醇水平，以帮助个体提高沟通与社交能力。[5][40]
神经增强不仅涉及强化短期和长期的智力（通常由各种类型的评估确定）、学习能力（如记忆强化）、专注或沉浸能力[9][41][42][43][40]，及通过各类心理测量所体现的指标，而且还涉及：
- 情绪（“增强情绪”）[25][44][35][40]
- 动机（“增强动机”）[41][37][38][42][45]
- 任务乐趣[46]
- 交际能力（与交谈或移情有关）[47][48][49][50][36][40]
- 作为不健康行为或物质的替代品（如物质使用障碍或冲动消费）[51][52][53][54]
- 意志力和自控力[55]
- 创造力[37][38][42][56][57]
- 认知耐力（如认知工作耐力[41][46][42]、抗疲劳能力[58]）[59]
- 特定能力与技能（如语言流畅性、解决问题与推理的反应时间等）[60][12][61][56]
- 心理复原力[62][63]
增强剂有生化、物理和行为层面上不同的增强策略。[64]乙酰半胱氨酸，一种低副作用的认知增强剂，与改善不健康的物质使用[51][52][65]或稳定情绪都有关系[66][67][68][69][70]。
莫达非尼
莫达非尼是觉醒促进剂之一，能减轻疲劳、提高警惕、减少白天过度嗜睡症状与改善情绪。[4][5][10]莫达非尼目前获准用于治疗嗜睡症、睡眠呼吸暂停和轮班工作睡眠紊乱等疾病，[2][5]目前也正被美国空军采用，以用于减轻机组人员执行长时间任务所带来的疲劳。莫达非尼在普通大众中也越来越受欢迎，在《自然》杂志进行的一次在线调查中，1400名读者中就有8.8%承认出于非医疗原因使用莫达非尼。他们使用莫达非尼的理由是为了提高注意力和对特定任务的专注度，或者是为了抵御睡眠不足和倒时差。[2]若将莫达非尼销售量与患者人数进行比较发现，两者的比例失调，表明对莫达非尼的滥用现象严重。[2]
莫达非尼被报告出，可以改善非有失眠症状的健康个体的执行能力，或改善注意力、学习能力与记忆力。[1]而莫达非尼对睡眠不足者的作用更为显著：单一剂量就已能提高清醒度、执行能力与记忆力。[10]在持续睡眠不足的情况下，重复服用莫达非尼有助于保持比安慰剂更高的清醒水平，但对改善注意力和执行能力没有帮助。[2][10]由于此类试验大多针对军人进行，因而还需进一步研究莫达非尼对普通人群的影响。莫达非尼或会损害人的自我监控能力，研究发现的常见趋势之一是：参与者对自己在认知测试中的表现评价高于实际水平，这表明存在“自负”效应。[2]
莫达非尼在普通人群中也越来越受欢迎，[8]除了希望借此改善自身神经系统性能，给药厂带来的经济利益也是原因之一。每年，莫达非尼的市场份额就超过7亿美元，表明除医用外的份额很高。[4]莫达非尼也是目前市场上，比较容易买到的神经增强药物之一。莫达非尼可以从许多网站（大多产自亚洲国家）或暗网市场上买到。[4][72][73]莫达非尼首次引起公众注意是在2003年田径世锦赛上，世界冠军长跑运动员凯莉·怀特因非法服用莫达非尼，被检测出阳性反应，因此也失去了两枚金牌。[4]
派醋甲酯
哌醋甲酯（MPH）又名利他林，是兴奋剂，用于治疗注意力缺陷多动障碍（ADHD）。但众所周知，哌醋甲酯在普通人群——尤其是在大学生中被大量滥用。[2][4]在《自然》杂志开展的一次在线调查中，1400名读者中有12.4%承认出于非医疗原因使用哌醋甲酯，使用MPH的理由是为了提高注意力、改善睡眠不足和倒时差。[2]
将MPH销售量与患者人数进行比较后发现，两者的比例失调，表明滥用现象严重。[2]MPH被认为对巩固记忆有积极作用，尽管研究未能最终证实此说法。[2][10]流行观点认为MPH能增强注意力，但这一观点同样未能得到证实。[2][10]MPH的研究报告指出，MPH能提高解题能力。然而，当重复研究以期复现结果时，安慰剂组的得分更高，这表明MPH甚至会损害成绩。[4]这些不确定的、普遍负面的记忆力改善研究结果，不足以解释出于非医疗用途使用MPH的原因。除了用于改善神经机能外，用药者还可能有其他动机，如主观和娱乐效果等，而这推动了其在无处方的情况下用药。[2]
美金刚胺
美金刚胺，一种NMDA受体拮抗剂，用于治疗中至重度阿茲海默症患者，但也被用作神经增强药物。[3]由于此类研究，大多是对美金刚的单剂量测试，而因此类药物，只有在持续摄入后才会显示出某些无论积极或消极的效果。因而，在此之前，单剂量美金刚研究不足以揭示该药物的实际潜力。[3]
多奈哌齐
多奈哌齐，一种乙酰胆碱酯酶抑制剂（AChEI），用于治疗轻至中度阿茲海默症患者。虽然，许多乙酰胆碱酯酶抑制剂都可能是潜在的神经增强物质，但因多奈哌齐被广泛用于治疗阿茲海默症，因而在普通人群中是属最常用的乙酰胆碱酯酶抑制剂。[3]
关于多奈哌齐的大多数研究都无法最终验证该药物具有神经增强的能力，[3]尽管这些研究中，服用多奈哌齐的参与者组得分高于服用安慰剂的参与者组。多奈哌齐能帮助患者保持训练任务、言语记忆和外显记忆。[3]在睡眠剥夺研究中，虽然多奈哌齐对休息良好的个体没有影响，但对被睡眠剥夺24小时的个体有积极影响，记忆力和注意力都得到了提高；若非如此，在如此睡眠不足的境地下，其记忆力和注意力就会出现缺陷。[3]不过，值得注意的是，此种效果仅出现在因睡眠不足，而成绩明显下降的人身上。[3]
研究和潜力药物
有相关研究探索了现有认知增强剂的衍生物，这些衍生物具有或可能具有更高的生物利用度，如乙酰半胱氨酸的衍生物N-乙酰-L-胱氨酸，和其他生物利用度增强策略。[75][76]另一种增强药效、效力或选择性（selectivity）的方法是改进给药方式，[77][78]开辟更多给药途径，如通过奈米乳液鼻内给药（"nose-to-brain" drug deliver），[79]或假设通过脑部植入给药。[80]
半衰期或也是研发课题之一。如，尽管莫达非尼能显著提高人的警觉性，但其半衰期长达约13小时，[81]会延迟或影响入睡时间与睡眠，[82][21]而目前市面上，也还没有短效的莫达非尼。根据2009年的两项研究，阿莫达非尼的消除速度，比外消旋莫达非尼的S-异构体慢约三倍。[83][81]
- 无论长短期——特别是对健康人群——使用药物的一般安全性和有效性。[42][84][85][7][40][57][34]（借助神经成像技术、[85]脑图谱分析、[86]神经影像智力测试。）
- 研究还可以测量经常使用莫达非尼等化学物质对动物模型的死亡率与寿命的影响。
- 不同方案（如剂量[60][7]、时间和安排）。
- 组合[77]（如并行、周期或顺序及前体、消耗[87][88]和辅因子）
- 影响因素（如情境、任务难度[98]、个人因素（如基因[7]或基础技能水平[60][98][61][40]）、与方案有关的因素等）[64][7]
- 相互作用（如多重用药和联合用药）[26][77]
- 利弊权衡类问题。[64][99][98][40]
脑内生物工程
短期内，无法用于人类的高级认知增强技术，可以建立在设计受体的研究基础上，并通过蛋白质激活或抑制神经元，如使用药物遗传学技术。[105] 经过基因改造的神经元可将外部元件与神经连接。[106]2020年，研究人员报告称，通过生物工程对秀丽隐杆线虫进行了改造，使其能够在脑细胞中合成、制造和组装生物电子材料，实现了对特定神经元群膜特性的调控，以及操纵活体动物的行为。[107][108][109]
如果有机神经形态设备达到一定程度，并具有生物相容性，就有可能实现新型大脑植入物。[110]还有有关潜在的可植入式物理人工神经元的研究。[111][112]基因工程或干细胞培育的神经组织的生物移植也有可能实现，[113]另种方法是通过湿件计算机达成。
膳食成分和补充剂
健脑食品所含各种化合物，以草药或分离物形式摄入，如：桂皮、[114]可可粉、[115][44][116][117][91] 花色素苷（如于 山桑子和西洋接骨木之中）、[118]硝酸盐（如于红菜头之中）、[91]蜂蜜、[119]多酚（存在于许多水果和蔬菜之中）、[91][120][121][122]儿茶素、[123][124] L-多巴[42]苯丙氨酸[125][126]和酪氨酸,[127][87]苯乙胺、[128]类胡萝卜素如番茄红素（于番茄酱中）[128]茶氨酸、[129][89][90]芹菜素（和洋甘菊）、[130][131]姜、[132][117][126]草本茶（尤为香蜂花、迷迭香、辣薄荷和含咖啡因的饮料）、[133][134][135][136][26][126]红景天、[77][85][126][137][138]肌酸、[139][140][141]Ω-3脂肪酸（如，藻类提取物）[146]以及纠正普遍存有的微量营养素缺乏症[147][148][149][150][126][151]研究其对健康年轻人认知能力，可能产生的微小，但显著的影响或叠加影响。
膳食中的葡萄糖（及其糖原形态）是大脑的主要能量来源，尽管直接摄入葡萄糖会影响健康，但一些研究人员认为葡萄糖是种“生化增强剂”，需要持续补充，但以单糖补充，会使血糖飙升，且其提供的葡萄糖供应，也不会持续太久。与快速吸收或高GI食物相比，吸收缓慢的含碳水化合物食物或低GI食物释放葡萄糖的速度较慢。[152][91][64][126]尽管脑葡萄糖代谢与神经退行性疾病有关，但有关脑葡萄糖代谢与认知能力之间联系的研究却很少。[153]乳酸（尤其是在特定类型的运动中释放）也可能与认知能力的提高有关。[154][155][156]
药物
正在进行早期研究的、具有显著潜在可行性的药剂——作为最终药剂或类似药剂的原型——有可能在特定情况下（如学习阶段）对健康青年人特殊层面产生影响。但至少在大多情况下、此类药剂、对人体的影响和安全性基本未知、因此未被广泛应用或没被应用、如： 食欲肽-A、[157]FGL、PTEN-PDZ和磷酸肌醇3-激酶PTD4-PI3KAc、[158] 益智二肽、[159][160][161]环丝氨酸、[162][163][164][40][165]多巴胺再摄取抑制剂CE-123和CE-158、[166]安帕金，如IDRA-21和CX717、[167][168][40][126][169]雷帕替奈、[170][171][172]ISRIB、[173][174]citicoline、[175]选择性受体调节剂、如MRK-016（作用于GABAA亚型受体）、[176]类似莫达非尼的CRL-40,940和modafiendz、[100]受莫达菲尼启发或混合型SNDRIJZ-IV-10和JZAD-IV-22、[177][178][179]TAK-925（食欲肽受体拮抗剂与莫达非尼有类似的觉醒作用）、[180][181]唤醒性或促认知性嗜睡症候选药物，如samelisant、[182][183]紫檀芪、[184][185]伊布莫仑、[186][187]H3受体拮抗剂替洛利生。[188][182][189]
一些药物、如广泛使用的、与社交能力相关的 GABA受体激动剂苯妥英钠、至少在某些剂量下——尽管不一定——会对某些人产生持久的重大副作用和成瘾可能性。[190][191][47][192]其他值得注意的再利用化学品已经被广泛用于其他目的、并具有潜在的神经增强功能、但在大多数情况下、没有或很少有针对青年人的研究。侧面研究显示有有限效应和或大小未知的药剂包括： 大麻二酚、[193][194]神经肽脑活素、[22][195]尼麦角林、[196][85]石杉碱甲、[197]二甲基乙醇胺和甲氯芬酯、[85][197][34]vinpocetine、[85][197] 十六酰胺乙醇（PEA）、[198]和砒硫醇。[199][85]
非药物方法
神经刺激
神经刺激方法目前正被研究与开发，研究结果表明，刺激程序的细节至关重要，否则会损害而非增强认知能力。人们对这种方法，能否在认知领域产生有意义的结果提出了质疑。刺激方法包括电刺激、磁刺激、激光光刺激、几种形式的声刺激以及神经反馈等物理刺激方法。[64][105]也有一种想法是，将可神经刺激的穿戴物集成至头盔之中。[157][105]
跨颅直流电刺激
如果说，神经增强药，是提高认知能力的方法之一，那么对运动皮层的跨颅直流电刺激（tDCS），则被视作另种方法。[200]tDCS最初是用于帮助脑损伤（如中风）患者。但在过去几年，人们对其在健康人身上的应用也产生了浓厚的兴趣。最近研究已表明，tDCS能改善神经可塑性，促进年轻人运动学习，因而，也有可能将这种方法应用到老年人群中。[200]
在一项研究中，用tDCS刺激大脑的高级认知功能区，如语言功能区，结果改善了受试者的单词检索能力。tDCS通过增强特定受刺激网络的连通性发挥作用，在对任务执行至关重要的高度特定脑区提供神经效率。[201]在此期间，fMRI图还显示语义检索过程活动减少，表明大脑任务关键区域的处理效率更高。[201]限定任务相关区域活动的减少，被认为有助于巩固运动学习与提高记忆能力。tDCS最新研究正试图定位刺激，以影响所需的高度特定的任务相关神经元子集。[201]2022 年，科学家们证实，跨颅直流电刺激可根据频率的不同，在一个月内改善65-88岁人群的短或长期记忆。[202]
脑深层刺激术
脑深层刺激术（DBS）是另一种神经强化疗法。与tDCS不同之处在于，DBS需要植入医疗设备，而且只限于帕金森病和肌张力障碍等少数严重疾病。[203]一项研究显示，在3个月的治疗过程中，DBS使肌张力障碍患者的运动能力提高39%，残疾程度降低38%，生活质量提高30%。[203]患者的肌张力障碍症状减轻50%。[203]DBS手术后的数小时至数天内，病情明显改善。目前，DBS的疗效远远超过大剂量三苯氧胺（一种用于治疗肌张力障碍的强效药物）。
脑波夹带
脑波夹带，也称脑波同步或神经夹带，是指观察到脑波（大脑中的大规模电振荡）会自然地与周期性外部刺激的节奏同步，如闪烁的灯光[204]、语言[205]、音乐[206]或触觉刺激。由于不同的意识状态，可能与不同的主导脑电波频率有关，[207]因此假设脑电波夹带可以诱导出一种理想的状态。如，研究人员发现，对慢波睡眠中的delta波，进行声波夹带具有改善健康受试者记忆力的功能效果。[208]一项研究表明，采用“视觉闪烁范式”，以个体自身的大脑节奏（即alpha波）对其进行诱导，可大大加快感知视觉学习速度，并在诱导后第二天依旧保持。特别是，在检测背景杂波中的目标，或识别噪声中的径向玻璃图案与同心玻璃图案的辨别任务中，与不进行alpha波诱导一组相比，诱导组大大加快了学习速度（该组“进步速度至少是对照组的三倍”）。[209]
环境因素
教育与时间分配
发展教育也可是神经强化一部分。神经科学和软件（如人工智能和自适应在线学习环境）方面的成果或与这一发展相关，[210][211][212][213]终身学习可被视为认知能力提升的方式之一。[41]
如何分配时间，可能会对认知产生重大影响，反之亦然。[23][215][28]而这可通过各种非药物方式调节，如决策、优先顺序、例行活动、反思实践、推理相关技术、游戏化[41]、激励措施等。一篇综述指出，采用“动机访谈、使用奖励或激励措施”等增强动机的措施，可使干预措施在改善健康行为方面，取得更大成功。[216]典型的活动包括睡眠、有偿劳动、学校、社交媒体、电视、志愿服务、锻炼、社交活动和业余爱好等。
时间分配
有有关时间分配的研究，也有关于各类媒体使用对认知影响的研究。屏幕时间和游戏行为对认知的影响，可能在很大程度上取决于活动、情境、替代活动和内容。[215][217]而使用认知增强剂药物的动机就包括“优化时间”和“增加清醒时间”。[21]
教育与认知
在课堂引入和整合多媒体等工具设备，可以提高认知能力和灵活性，降低认知负荷，也可培养数位素养。[218][213]批判性思维、技术支持的探究学习、科学推理能力和解决问题的技能，可能与认知领域有关，或为“元认知技能”。[219][220][213][221][222][223]教育改进或可视为提高认知能力，“教育者”常犯一种谬误，即当他们采用“应试教育”和优先考虑“记忆，而非批判性思维与解决问题等可推广的技能”时，他们会假定如果“个别独特的认知过程可以得到提高[......][这]就一定会提高整体认知能力”此种谬误。[224]
基因强化
基因工程是未来潜在的认知增强生化策略之一，目前仅在动物模型中进行了初步但成功的测试，还不是研究人员可选取的增强方法。[64][28][225]
候选靶基因
乔治·丘奇根据科学研究汇编了一份基因改造清单，进行改造会带来有利成效，如减少睡眠需求、与认知相关的变化（如预防阿茲海默症）、抗病能力、更高的瘦肌肉质量与更强的学习能力，及相关的研究与潜在的负面影响。[226][227]一项神经遗传学全基因组关联分析元分析调查有关语言技能的遗传相关性，报告了迄今为止人类独有的语言相关能力的遗传因素，特别是五个测试特征技能水平差异的因素，也还使用了神经解剖学、神经影像学的数据。[228]但，相关性不等同因果性，因果性既不一定独立于社会因素，也不一定完全有用。
范围
神经强化的主要着重点，如优化儿童发育因素及延缓、逆转或减轻大脑老化。[229]而增强人类记忆与学习能力的尝试，在科学领域也有着悠久历史。[230]
支持提升认知能力的人认为，认知能力提升对劳动力，尤为老年劳动力有巨大的潜在益处。[200][77]因为上世纪医疗技术的大幅提高，人类平均预期寿命随之大幅增加。发达国家的人口统计数据显示，老年劳动力迅速增长。但，年龄增长通常打击学习新技能之能力，而现今，行业整合比以往任何时候，都更需要员工能够获取和保留新技能的能力。[200]随着老龄人口增加，与年龄有关的失调和疾病，所造成的经济、社会和健康负担也随之增加。[77]最近，“由于全球老龄比例不断增加，而且预计与年龄相关的大脑认知功能衰退也会加剧”，增强认知功能的问题也愈发受到人们关注。[230]
一篇评论指出，“即使是身体正常的年轻人，因睡眠不足、时差或其他压力因素，也并不总是正常发挥身体机能，有些人，可能需要认知增强剂才能在某些情况下发挥最佳水平”。[99]因此，神经增强涉及的是提高各认知领域的能力，使其在更多和更具体的时间内接近并提高最佳水平，及改善神经心理之弱点或并非疾病的轻度缺陷。
副作用
常见的神经增强药物，通常对健康人有着很好的耐受。[2][3]而此类药物已成为治疗各类精神疾病患者的主流药物。由于有关神经增强剂及其功能的大部分信息都源于研究实验，因此，确定不良反应的最佳方法，是脱落率指标与用药者的主观评价。多奈哌齐、美金刚胺、派醋甲酯和莫达非尼的脱落率极低或根本没有。[2][3]在药物试验中，参与者报告了服用多奈哌齐、美金刚、派醋甲酯或莫达非尼后，出现有以下不良反应：胃肠道不适（恶心）、头痛、头晕、做噩梦、焦虑、嗜睡、紧张、不安、睡眠障碍和失眠，但副作用通常会在治疗过程中消去。[3]虽然没有关于脑深层刺激手术副作用的报告，但有18%的患者报告了与设备相关的并发症，如导线脱落或断裂导致的感染。[203]各种因素，如剂量、时间和行为之因素，都可能形成，或决定副作用出现。但，认知增强剂被广泛使用，但其对健康的长或短期影响，几乎完全未知，或已知对健康不利。
伦理、社会和法律问题
对健康的不利影响与依赖性
家长与医疗保健师对使用各类神经增强剂的人之安全与健康状况感到担忧。[233]2011年，在杰恩·卢克（Jayne Lucke）发表的一篇文章中，将神经增强的概念与西地那非作比较，指出“西地那非的娱乐性使用者对自己勃起能力的信心低于非使用者，尽管他们的勃起功能明显更好。他们对这些药物产生了心理依赖”。作者认为，神经增强剂使用者也会出现类似的问题。[233]此外，会有高估预期干预措施，或认为其超过实际效果之情况，而过度自信。[2][24]
若越多人参与进促智队伍一员，那或会导致人们“最终会感到，自己受到了微妙的胁迫，不得不参与进来，以便在学校或职场中保持竞争力”，又或是在军队中，或是受到同伴的各种压力而参与其中。[157][234][46]Dubljević指出，“确保纳税人充分知情、跟踪任何不利影响，并由筹集资金（如通过税收或收费）以解决相关社会问题至关重要”，表明政府也可以在应对神经增强挑战方面发挥更积极的作用。[235]在医疗系统中，若没采取调整生产措施，如提高产量、降低生产成本，那样调整，神经增强可能会诱发“处方药转移”现象，分散治疗用处方药之比例。[34]一篇评论假设，近期针对健康个体的随机对照试验样本量有限，部分原因或是研究受到媒体与生物伦理文献影响，这些文献围绕着在健康受试者中使用药物增强认知能力的伦理等主题展开论述。[7]
安全与质量控制
对于包括膳食补充剂与治疗药品在内的认知增强剂，似乎缺乏各种要求、质量标准、验证和鉴定流程、抽样调查与实验室检测等措施，或为治理失败之果。[236][237][238][239][240][241]意味着，尽管用药者可能是完全了解当前关于化学品利弊与个人用药因素的有关知识，药品仍可能存有，与标签不同或质量较差的风险，[242]这在某些情况下，会造成危险。[243]一项研究，提出了一份建议：“创立知识库——作为学校和成人教育中，有关营养与健康教育的一部分，使人们能够抵制与食品补充剂有关的营销与广告，权衡利弊，知悉潜在健康风险”。[244]
认知多样性和不平等
神经强化常被与体育运动中的兴奋剂问题类比，因此有时也被称其为脑兴奋剂。[233][23][190][25][57]人们普遍关注问题之一是，服用提高成绩药物的人，比不服用的人，享有不公平的优势。但许多运动员认为，要想战胜使用能提高成绩的药物的运动员，唯一方法是，自己也用；看待服用神经增强药物的人时，普通人想法类似。[233]在一项针对18至34岁青少年的调查研究中，50%的青少年对使用兴奋剂的概念几乎没有异议。[233]尤其是学生群体，往往认为认知神经增强剂，可被接受。[233]
通常讲，以神经增强为目的的此类药物，道德可接受性（包括公平观念）是决定使用或不使用这类药物重要因素之一。研究表明，对此类药物的道德反对，大幅降低了使用此类药物的意愿。[245][246][247]许多人认为，监管神经增强剂的唯一出路是允许所有人使用，从而最大限度地减少以此带来的不公平优势。另一方面，禁止使用这些药物可能会对社会造成有害影响，[8]因为这不仅会形成黑市，扩大非法使用造成的问题，还会增加社会执法成本。[233]因此，需要对神经增强药物利弊进一步评估，使决策者更容易对此类药物的监管做出决定。[10]
总的来说，认知多样性——或某种“最佳多样性范围”——或许有价值。科技进步带来的新能力，自然会引发相关的伦理问题。[248]还有人推测，认知增强技术（CET），也可能会增加认知多样性，如，不同的人会选择增强其认知的不同方面。[249]此外，认知能力的提高，也可能会减少不平等现象，[250]如通过“公平竞争”以及缩小“基因抽签”带来的不平等。[7]
分配正义
另一问题是分配正义，涉及“谁能获得，新的认知增强技术”与“谁能体验到其益处”之问。[234][99][113][34]影响认知增强剂成本，主要因素之一，便是其专利性，不利于降低成本推广。[64]网上药店可以大幅降低成本，提高可负担性，使消费者得以支付得起某些药品。[240][251][252]天然制剂（少量存于食物）可以“为社会经济背景较差，或居住在较贫穷国家的患者提供更多选择”。[77]艾伦·布坎南在其著作中建议，“我们应该抓住这一新兴药物技术提供的机遇，投入资源，确保这些药物得到适当的开发与测试、确保获得这些药物的机会平等且开放，以避免不公正和黑市的发展”。[253]
认知自由与自主
Sententia将认知自由之实际应用表示为两个原则：
- 只要行为不危及他人，就不应违背个人意愿，强迫他们使用与大脑直接交互的技术，也不应强迫他们服用某些精神药物。
- 只要个人随后不从事伤害他人的行为，就不应禁止他们使用新的增强思维的药物和技术，也不应将其定罪。[254]
第一原则旨在保护个人免受国家、公司或其他个人干扰认知过程，第二原则旨在确保个人拥有改变与增强自身意识之自由。[255]享有认知自由之个体，可以自由地，以任何方式改变自己的心理过程，无论通过冥想、瑜伽或祈祷等间接方式，或，通过精神药物与神经技术进行直接的认知干预来达到。由于精神药物是强有力改变认知功能方法之一，许多主张认知自由的人，同时也倡导药物相关立法改革；他们声称，“对毒品的战争”实际上是“对精神状态的战争”。[256]认知自由与伦理中心（Center for Cognitive Liberty and Ethics，CCLE）及其他倡导认知自由的组织，一直在游说重新审查与改革违禁药物法；CCLE的主要指导原则之一是：“政府不应在刑事上禁止认知增强或体验任何精神状态”。[257]还有人以认知自由为由，呼吁改革对使用百忧解、利他林和阿德拉等增强认知能力的处方药之限制。[258]
认知自由对超人类主义运动支持者而言，也同样重要，超人类主义运动关键信条之一，便是增强人类的精神功能。Wrye Sententia强调了认知自由，在确保追求人类精神增强的自由，及选择反对增强的自由方面的有着相当重要性。[259]Sentia认为，承认“指导、修改或强化个人思维过程的权利（以及不如此做的权利）”对于自由应用新兴神经技术，以增强人类认知能力至关重要；而且需要超越当前的思想自由概念。[260]Sentia称，“认知自由的优势在于，它既能保护那些确实想改变大脑的人，也能保护那些不想改变大脑的人”。[259]
人权
许多人权倡议者业已提出许多相关神经增强的人权倡议。[261][262] 2023年，在妮塔·A·法拉尼出版一本书中，提出了一项新的有关认知自由的人权倡议，作为“对现有的隐私权、思想自由权和自决权等其他人权的更新”，部分原因是一些神经增强技术也可能被用于“非自愿神经监控”等方式（包括商业目的），而容易受到黑客攻击或被用于操纵。[263][264][265]还有人提出“认知自由权、精神隐私权、精神完整权和心理连续性权”等权利。[261]2021年，智利成为第一个批准神经法的国家，规定了有关个人身份、自由意志和精神隐私的权利。[266]
流行文化
神经增强药在一些小说和电影中扮演着重要角色，如2011年的《药命效应》，该片在一定程度上，以富有想象力的方式，探究与探讨了使用神经增强药的机遇与威胁。[267]
观点
公众观点
公众对神经增强问题的看法不一。[233][268]通常说，25岁以下的年轻人，认为神经增强剂可被接受，或说决定权于个人手中。医疗保健官员和家长则担忧，如安全因素、缺乏有关这些药物完整信息，及可能出现的不可逆之不良影响。[233]事实证明，这些担忧，会降低使用此类药物的意愿。[269][270][246]
2016年，德国对6454名受访者进行的一项研究发现，认知增强药物的终身使用率相当低（2.96%），而每十名受访者中，就有一人愿意服用此类药物（10.45%）。[271]据研究估计，美国有7-9%的大学生服用神经增强药物。有些研究估计这一数字高达12%，甚至20%。[268]一项对5000多名德国大学生进行随机抽样大规模调查发现，30天内使用此类药物的比例相对较低，分别为1.2%、2.3%、3.2%和4.6%。[269]在过去6个月内，使用过此类药物的学生中，39.4%表示在此期间使用过一次，24.2%使用过两次，12.1%使用过三次，24.2%使用过三次以上。研究表明，神经增强药物的消费者更愿意在未来使用这些药物，例如，由于药物带来的积极体验或成瘾倾向。[247][272]学生们认为使用这些药物，主要是为了提高注意力、提高警觉性或“嗨”起来。[233][268]
神经增强药物使用者对神经增强药物积极潜力的评价高于非使用者，而对这些药物不良反应的评价低于非使用者，这表明他们对这些药物的效果更有信心。在一项针对1324名德国学生的调查中，32%不服用神经增强药物的受访者，认为这些药物具有积极促认知效果，12%参与者认为这些药物具有放松效果。[268]相比之下，54%的服用神经增强药物的参与者认为这些药物具有积极的认知效果，25%的人认为这些药物具有放松效果。
对保持“警觉”与“专注”的需求，也可以从咖啡因消费的趋势中看出。在美国，学生和普通人的咖啡因消耗量都在90%左右。服用神经增强剂的学生服用大麻等精神活性药物的频率也更高。一项针对德国大学教师（包括教授）的研究发现，其使用神经增强药物的比例非常低。[247]只有0.9%的受访者报告使用过这类药物。不过，10%的受访者愿意在未来服用此类药物，这或表明此类药物的流行率或会上升。与工作有关的压力是使用这类药物的原因之一。
医生
医生在确定神经增强药物的潜在滥用方面发挥重要作用。有些神经增强药物无需处方，容易买到，而其他需要处方的药物，则由医生自行决定。在对瑞士精神科医生和全科医生进行的一项调查中，大多数受访医生一致认为，他们判断功能障碍是否应被视为疾病的标准是，患者是否表示出主观痛苦或对日常工作能力造成负面影响。[6]不过，大多数接受调查的医生都认为，如果没有明确的功能障碍迹象，他们不会开药。[6]
参考文献
引用
- ^ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Battleday, Ruairidh; Brem, Anna-Katharine. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review. European Neuropsychopharmacology. 28 July 2015, 25 (11): 1865–1881. PMID 26381811. S2CID 23319688. doi:10.1016/j.euroneuro.2015.07.028.
- ^ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 Repantis, Dimitris; Schlattmann, Peter. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research. 2010, 62 (3): 187–206. PMID 20416377. doi:10.1016/j.phrs.2010.04.002.
- ^ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 Repantis, Dimitris. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research. June 2010, 61 (6): 473–481. PMID 20193764. doi:10.1016/j.phrs.2010.02.009.
- ^ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 Normann, Claus; Berger, Mathias. Neuroenhancement: status quo and perspectives (PDF). European Archives of Psychiatry and Clinical Neuroscience. November 2008, 258: 110–114 [2023-08-13]. PMID 18985306. S2CID 9733191. doi:10.1007/s00406-008-5022-2. （原始内容存档 (PDF)于2019-11-21）.[1] （页面存档备份，存于互联网档案馆）
- ^ 5.0 5.1 5.2 5.3 5.4 Normann, Claus; Nissen, C. Neuroenhancement strategies for psychiatric disorders: rationale, status quo and perspectives. European Archives of Psychiatry and Clinical Neuroscience. November 2012, 262: 113–116. PMID 22932721. S2CID 42536705. doi:10.1007/s00406-012-0356-1.
- ^ 6.0 6.1 6.2 6.3 6.4 Ott, R. Neuroenhancement - perspectives of Swiss psychiatrists and general practitioners. Swiss Medical Weekly. 2012, 142: w13707. PMID 23254869. doi:10.4414/smw.2012.13707
.
- ^ 7.0 7.1 7.2 7.3 7.4 7.5 7.6 7.7 Fond, Guillaume; Micoulaud-Franchi, Jean-Arthur; Brunel, Lore; Macgregor, Alexandra; Miot, Stéphanie; Lopez, Régis; Richieri, Raphaëlle; Abbar, Mocrane; Lancon, Christophe; Repantis, Dimitris. Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review. Psychiatry Research. 30 September 2015, 229 (1): 12–20. ISSN 0165-1781. PMID 26187342. S2CID 23647057. doi:10.1016/j.psychres.2015.07.006 （英语）.
- ^ 8.0 8.1 8.2 Veit, Walter. Cognitive Enhancement and the Threat of Inequality. Journal of Cognitive Enhancement. 2018, 2 (4): 404–410. S2CID 158643005. doi:10.1007/s41465-018-0108-x .
- ^ 9.0 9.1 9.2 9.3 9.4 9.5 Franke, A. G.; Northoff, R.; Hildt, E. The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective. Pharmacopsychiatry. November 2015, 48 (7): 256–264. PMID 26252723. S2CID 7179775. doi:10.1055/s-0035-1559640.
- ^ 10.0 10.1 10.2 10.3 10.4 10.5 10.6 Ragan, Ian; Bard, I; Singh, I; Independent Scientific Committee on Drugs. What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology. February 2013, 64: 588–595. PMID 22732441. S2CID 207227699. doi:10.1016/j.neuropharm.2012.06.016.
- ^ Mereu, Maddalena; Bonci, Antonello; Newman, Amy Hauck; Tanda, Gianluigi. The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology. 1 October 2013, 229 (3): 415–434. ISSN 1432-2072. PMC 3800148 . PMID 23934211. doi:10.1007/s00213-013-3232-4 （英语）.
- ^ 12.0 12.1 12.2 12.3 12.4 Al-Shargie, Fares; Tariq, Usman; Mir, Hasan; Alawar, Hamad; Babiloni, Fabio; Al-Nashash, Hasan. Vigilance Decrement and Enhancement Techniques: A Review. Brain Sciences. August 2019, 9 (8): 178. ISSN 2076-3425. PMC 6721323 . PMID 31357524. doi:10.3390/brainsci9080178 （英语）.
- ^ [1][4][5][10][11][12]
- ^ Kongkeaw, Chuenjid; Dilokthornsakul, Piyameth; Thanarangsarit, Phurit; Limpeanchob, Nanteetip; Norman Scholfield, C. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. Journal of Ethnopharmacology. 10 January 2014, 151 (1): 528–535. ISSN 0378-8741. PMID 24252493. doi:10.1016/j.jep.2013.11.008 （英语）.
- ^ Aguiar, Sebastian; Borowski, Thomas. Neuropharmacological Review of the Nootropic Herb Bacopa monnieri. Rejuvenation Research. 1 August 2013, 16 (4): 313–326. ISSN 1549-1684. PMC 3746283 . PMID 23772955. doi:10.1089/rej.2013.1431.
- ^ 16.0 16.1 Lorca, Cristina; Mulet, María; Arévalo-Caro, Catalina; Sanchez, M. Ángeles; Perez, Ainhoa; Perrino, María; Bach-Faig, Anna; Aguilar-Martínez, Alicia; Vilella, Elisabet; Gallart-Palau, Xavier; Serra, Aida. Plant-derived nootropics and human cognition: A systematic review. Critical Reviews in Food Science and Nutrition. 3 January 2022: 1–25. PMID 34978226. S2CID 245651213. doi:10.1080/10408398.2021.2021137.
- ^ Kean, James D.; Downey, Luke A.; Stough, Con. Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents. Medicines. December 2017, 4 (4): 86. ISSN 2305-6320. PMC 5750610 . PMID 29165401. doi:10.3390/medicines4040086 （英语）.
- ^ Lorca, Cristina; Mulet, María; Arévalo-Caro, Catalina; Sanchez, M. Ángeles; Perez, Ainhoa; Perrino, María; Bach-Faig, Anna; Aguilar-Martínez, Alicia; Vilella, Elisabet; Gallart-Palau, Xavier; Serra, Aida. Plant-derived nootropics and human cognition: A systematic review. Critical Reviews in Food Science and Nutrition. 3 January 2022: 1–25. ISSN 1040-8398. PMID 34978226. S2CID 245651213. doi:10.1080/10408398.2021.2021137.
- ^ [14][15][16][17][18]
- ^ 20.0 20.1 20.2 20.3 Franke, A.G.; Lieb, K. Pharmakologisches Neuroenhancement und "Hirndoping". Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 1 August 2010, 53 (8): 853–860. ISSN 1437-1588. PMID 20700786. doi:10.1007/s00103-010-1105-0 （德语）.
- ^ 21.0 21.1 21.2 21.3 Esposito, Massimiliano; Cocimano, Giuseppe; Ministrieri, Federica; Rosi, Giuseppe Li; Nunno, Nunzio Di; Messina, Giovanni; Sessa, Francesco; Salerno, Monica. Smart drugs and neuroenhancement: what do we know?. Frontiers in Bioscience-Landmark. 30 August 2021, 26 (8): 347–359. ISSN 2768-6701. PMID 34455764. doi:10.52586/4948.
- ^ 22.0 22.1 22.2 22.3 22.4 Losch, D.; Schulze, J. Neuroenhancement. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie. 1 November 2019, 69 (6): 368–371. ISSN 2198-0713. S2CID 240645044. doi:10.1007/s40664-019-0340-y （德语）.
- ^ 23.0 23.1 23.2 Iglseder, Bernhard. Doping für das Gehirn. Zeitschrift für Gerontologie und Geriatrie. 1 February 2018, 51 (2): 143–148. ISSN 1435-1269. PMID 29209802. doi:10.1007/s00391-017-1351-y （德语）.
- ^ 24.0 24.1 Caviola, Lucius; Faber, Nadira S. Pills or Push-Ups? Effectiveness and Public Perception of Pharmacological and Non-Pharmacological Cognitive Enhancement. Frontiers in Psychology. 2015, 6: 1852. ISSN 1664-1078. PMC 4667098 . PMID 26696922. doi:10.3389/fpsyg.2015.01852 .
- ^ 25.0 25.1 25.2 Daubner, Johanna; Arshaad, Muhammad Imran; Henseler, Christina; Hescheler, Jürgen; Ehninger, Dan; Broich, Karl; Rawashdeh, Oliver; Papazoglou, Anna; Weiergräber, Marco. Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives. Neural Plasticity. 13 January 2021, 2021: 1–27. ISSN 1687-5443. PMC 7817276 . PMID 33519929. doi:10.1155/2021/8823383 （英语）.
- ^ 26.0 26.1 26.2 Tang, Siu W.; Tang, Wayne H.; Leonard, Brian E. Managing interactions between cognitive enhancers and other psychotropics. International Clinical Psychopharmacology (Ovid Technologies (Wolters Kluwer Health)). 2017, 32 (4): 175–183. ISSN 0268-1315. doi:10.1097/yic.0000000000000172.
- ^ [20][9][12][21][22][16][23][24][25][26]
- ^ 28.0 28.1 28.2 Jangwan, Nitish Singh; Ashraf, Ghulam Md; Ram, Veerma; Singh, Vinod; Alghamdi, Badrah S.; Abuzenadah, Adel Mohammad; Singh, Mamta F. Brain augmentation and neuroscience technologies: current applications, challenges, ethics and future prospects. Frontiers in Systems Neuroscience. 2022, 16. PMC 9538357 . PMID 36211589. doi:10.3389/fnsys.2022.1000495 .
- ^ Nair, Prashant. Brain–machine interface. Proceedings of the National Academy of Sciences. 2013-11-12, 110 (46): 18343. Bibcode:2013PNAS..11018343N. ISSN 0027-8424. PMC 3831969 . PMID 24222678. doi:10.1073/pnas.1319310110 .
- ^ "nootropic"[Title/Abstract] OR "smart drug"[Title/Abstract] - Search Results - PubMed. PubMed. [20 March 2023] （英语）.
- ^ Wood, Suzanne; Sage, Jennifer R.; Shuman, Tristan; Anagnostaras, Stephan G. Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation. Pharmacological Reviews. 1 January 2014, 66 (1): 193–221. ISSN 0031-6997. PMC 3880463 . PMID 24344115. doi:10.1124/pr.112.007054 （英语）.
- ^ Schifano, Fabrizio; Catalani, Valeria; Sharif, Safia; Napoletano, Flavia; Corkery, John Martin; Arillotta, Davide; Fergus, Suzanne; Vento, Alessandro; Guirguis, Amira. Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals. Drugs. 1 April 2022, 82 (6): 633–647. ISSN 1179-1950. PMID 35366192. S2CID 247860331. doi:10.1007/s40265-022-01701-7 （英语）.
- ^ Wingelaar-Jagt, Yara Q.; Bottenheft, Charelle; Riedel, Wim J.; Ramaekers, Johannes G. Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial. Journal of Psychopharmacology. February 2023, 37 (2): 172–180. ISSN 0269-8811. PMC 9912306 . PMID 36515156. doi:10.1177/02698811221142568 （英语）.
- ^ 34.0 34.1 34.2 34.3 34.4 34.5 Graf, William D.; Nagel, Saskia K.; Epstein, Leon G.; Miller, Geoffrey; Nass, Ruth; Larriviere, Dan. Pediatric neuroenhancement: Ethical, legal, social, and neurodevelopmental implications. Neurology. 26 March 2013, 80 (13): 1251–1260. ISSN 0028-3878. PMID 23486879. S2CID 207122859. doi:10.1212/WNL.0b013e318289703b （英语）.
- ^ 35.0 35.1 Weiergräber, Marco; Ehninger, Dan; Broich, Karl. Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background. Medizinische Monatsschrift für Pharmazeuten. 1 April 2017, 40 (4): 154–164. ISSN 0342-9601. PMID 29952165.
- ^ 36.0 36.1 36.2 Marazziti, Donatella; Avella, Maria Teresa; Ivaldi, Tea; Palermo, Stefania; Massa, Lucia; Della Vecchia, Alessandra; Basile, Lucia; Mucci, Federico. Neuroenhancement: state of the art and future perspectives. Clinical Neuropsychiatry. June 2021, 18 (3): 137–169. PMC 8629054 . PMID 34909030. doi:10.36131/cnfioritieditore20210303.
- ^ 37.0 37.1 37.2 d'Angelo, L‐S Camilla; Savulich, George; Sahakian, Barbara J. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure. British Journal of Pharmacology (Wiley). 2017-05-12, 174 (19): 3257–3267. ISSN 0007-1188. doi:10.1111/bph.13813.
- ^ 38.0 38.1 38.2 Brühl, Annette B.; d'Angelo, Camilla; Sahakian, Barbara J. Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?. Brain and Neuroscience Advances. January 2019, 3: 239821281881601. PMC 7058249 . PMID 32166175. doi:10.1177/2398212818816018.
- ^ Bornemann, Joel. The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review. Journal of Psychoactive Drugs. 7 August 2020, 52 (4): 300–308. ISSN 0279-1072. PMID 32362269. S2CID 218493319. doi:10.1080/02791072.2020.1761573.
- ^ 40.0 40.1 40.2 40.3 40.4 40.5 40.6 40.7 40.8 de Jongh, Reinoud; Bolt, Ineke; Schermer, Maartje; Olivier, Berend. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews (Elsevier BV). 2008, 32 (4): 760–776. ISSN 0149-7634. doi:10.1016/j.neubiorev.2007.12.001.
- ^ 41.0 41.1 41.2 41.3 41.4 Sahakian, Barbara J.; Bruhl, Annette B.; Cook, Jennifer; Killikelly, Clare; Savulich, George; Piercy, Thomas; Hafizi, Sepehr; Perez, Jesus; Fernandez-Egea, Emilio; Suckling, John; Jones, Peter B. The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people. Philosophical Transactions of the Royal Society B: Biological Sciences. 19 September 2015, 370 (1677): 20140214. ISSN 0962-8436. PMC 4528826 . PMID 26240429. doi:10.1098/rstb.2014.0214 （英语）.
- ^ 42.0 42.1 42.2 42.3 42.4 42.5 Brühl, Annette B.; Sahakian, Barbara J. Drugs, games, and devices for enhancing cognition: implications for work and society. Annals of the New York Academy of Sciences. 2016, 1369 (1): 195–217 [2023-08-15]. Bibcode:2016NYASA1369..195B. PMID 27043232. S2CID 5111793. doi:10.1111/nyas.13040. （原始内容存档于2023-03-12）.
- ^ Burk, Joshua A.; Blumenthal, Sarah A.; Maness, Eden B. Neuropharmacology of attention. European Journal of Pharmacology (Elsevier BV). 2018, 835: 162–168. ISSN 0014-2999. doi:10.1016/j.ejphar.2018.08.008.
- ^ 44.0 44.1 Tuenter, Emmy; Foubert, Kenn; Pieters, Luc. Mood Components in Cocoa and Chocolate: The Mood Pyramid. Planta Medica. August 2018, 84 (12/13): 839–844. ISSN 0032-0943. PMID 29539647. S2CID 3912460. doi:10.1055/a-0588-5534 （英语）.
- ^ Marcora, Samuele. Can Doping be a Good Thing? Using Psychoactive Drugs to Facilitate Physical Activity Behaviour. Sports Medicine. 1 January 2016, 46 (1): 1–5. ISSN 1179-2035. PMID 26497149. S2CID 13448073. doi:10.1007/s40279-015-0412-x （英语）.
- ^ 46.0 46.1 46.2 Porsdam Mann, Sebastian; Sahakian, Barbara J. The increasing lifestyle use of modafinil by healthy people: safety and ethical issues. Current Opinion in Behavioral Sciences. 1 August 2015, 4: 136–141. ISSN 2352-1546. S2CID 53198934. doi:10.1016/j.cobeha.2015.05.004 （英语）.
- ^ 47.0 47.1 Mun, Monique; Wong, Andrew. Kratom and Phenibut: A Concise Review for Psychiatric Trainees. American Journal of Psychiatry Residents' Journal. 14 December 2020, 16 (2): 6–8. ISSN 2474-4662. S2CID 230589322. doi:10.1176/appi.ajp-rj.2020.160203 （英语）.
- ^ Peele, Stanton; Brodsky, Archie. Exploring psychological benefits associated with moderate alcohol use: a necessary corrective to assessments of drinking outcomes?. Drug and Alcohol Dependence. 10 November 2000, 60 (3): 221–247. ISSN 0376-8716. PMID 11053757. doi:10.1016/S0376-8716(00)00112-5 （英语）.
- ^ Wudarczyk, Olga A.; Earp, Brian D.; Guastella, Adam; Savulescu, Julian. Could intranasal oxytocin be used to enhance relationships? Research imperatives, clinical policy, and ethical considerations. Current Opinion in Psychiatry. September 2013, 26 (5): 474–484. PMC 3935449 . PMID 23880593. doi:10.1097/YCO.0b013e3283642e10.
- ^ Buckner, Julia D.; Morris, Paige E.; Abarno, Cristina N.; Glover, Nina I.; Lewis, Elizabeth M. Biopsychosocial Model Social Anxiety and Substance Use Revised. Current Psychiatry Reports. 17 April 2021, 23 (6): 35. ISSN 1535-1645. PMID 33864136. S2CID 233261493. doi:10.1007/s11920-021-01249-5 （英语）.
- ^ 51.0 51.1 Peltier, MacKenzie R.; Sofuoglu, Mehmet. Chapter 23 - Pharmacological cognitive enhancers. Cognition and Addiction. Academic Press. 1 January 2020: 303–320. ISBN 978-0-12-815298-0 （英语）.
- ^ 52.0 52.1 Brady, Kathleen T.; Gray, Kevin M.; Tolliver, Bryan K. Cognitive enhancers in the treatment of substance use disorders: Clinical evidence. Pharmacology Biochemistry and Behavior. 1 August 2011, 99 (2): 285–294. ISSN 0091-3057. PMC 3114106 . PMID 21557964. doi:10.1016/j.pbb.2011.04.017 （英语）.
- ^ Kampman, Kyle M. The treatment of cocaine use disorder. Science Advances. 4 October 2019, 5 (10): eaax1532. Bibcode:2019SciA....5.1532K. ISSN 2375-2548. PMC 6795516 . PMID 31663022. doi:10.1126/sciadv.aax1532 （英语）.
- ^ Fluyau, Dimy; Cook, Sarah Clare; Chima, Ashmeer; Kailasam, Vasanth Kattalai; Revadigar, Neelambika. Pharmacological management of psychoactive substance withdrawal syndrome. Drugs & Therapy Perspectives. 1 November 2021, 37 (11): 519–535. ISSN 1179-1977. S2CID 244583239. doi:10.1007/s40267-021-00874-7 （英语）.
- ^ Erler, Alexandre; Forlini, Cynthia. Neuroenhancement. philpapers.org. 2020 [2023-08-17]. （原始内容存档于2023-04-08） （英语）.
- ^ 56.0 56.1 Beda, Zsolt; Smith, Steven M.; Orr, Joseph. Creativity on demand – Hacking into creative problem solving. NeuroImage. 1 August 2020, 216: 116867. ISSN 1053-8119. PMID 32325208. S2CID 215823256. doi:10.1016/j.neuroimage.2020.116867 （英语）.
- ^ 57.0 57.1 57.2 Lanni, Cristina; Lenzken, Silvia C.; Pascale, Alessia; Del Vecchio, Igor; Racchi, Marco; Pistoia, Francesca; Govoni, Stefano. Cognition enhancers between treating and doping the mind. Pharmacological Research (Elsevier BV). 2008, 57 (3): 196–213. ISSN 1043-6618. doi:10.1016/j.phrs.2008.02.004.
- ^ Neuroenhancement in Military Personnel: Conceptual and Methodological Promises and Challenge. [10 March 2023]. （原始内容存档于2022-09-08） （英语）.
- ^ Tennison, Michael N.; Moreno, Jonathan D. Neuroenhancement and Therapy in National Defense Contexts. The Routledge Handbook of Neuroethics. 2017: 150–165 [2023-08-15]. ISBN 9781315708652. doi:10.4324/9781315708652-12. （原始内容存档于2023-04-08）.
- ^ 60.0 60.1 60.2 Crawford, Cindy; Teo, Lynn; Lafferty, Lynn; Drake, Angela; Bingham, John J.; Gallon, Matthew D.; O'Connell, Meghan L.; Chittum, Holly K.; Arzola, Sonya M.; Berry, Kevin. Caffeine to optimize cognitive function for military mission-readiness: a systematic review and recommendations for the field. Nutrition Reviews. June 2017, 75 (suppl_2): 17–35. PMID 28969341. doi:10.1093/nutrit/nux007.
- ^ 61.0 61.1 Bagot, Kara Simone; Kaminer, Yifrah. Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review. Addiction. 2014, 109 (4): 547–557. PMC 4471173 . PMID 24749160. doi:10.1111/add.12460.
- ^ Mahdiani, Hamideh; Ungar, Michael. Can biomedical and cognitive enhancement increase psychological resilience?. Canadian Psychology. August 2021, 62 (3): 295–303. ISSN 1878-7304. S2CID 216387797. doi:10.1037/cap0000217 （英语）.
- ^ Budde, Henning; Wegner, Mirko. The Exercise Effect on Mental Health: Neurobiological Mechanisms. CRC Press. 17 April 2018 [2023-08-15]. ISBN 978-1-4987-3953-5. （原始内容存档于2023-04-17） （英语）.
- ^ 64.0 64.1 64.2 64.3 64.4 64.5 64.6 64.7 Dresler, Martin; Sandberg, Anders; Bublitz, Christoph; Ohla, Kathrin; Trenado, Carlos; Mroczko-Wąsowicz, Aleksandra; Kühn, Simone; Repantis, Dimitris. Hacking the Brain: Dimensions of Cognitive Enhancement. ACS Chemical Neuroscience. 20 March 2019, 10 (3): 1137–1148. ISSN 1948-7193. PMC 6429408 . PMID 30550256. doi:10.1021/acschemneuro.8b00571 （英语）.
- ^ Sherman, Brian J.; McRae-Clark, Aimee L. Treatment of Cannabis Use Disorder: Current Science and Future Outlook. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. May 2016, 36 (5): 511–535. PMC 4880536 . PMID 27027272. doi:10.1002/phar.1747 （英语）.
- ^ Bortolato, Beatrice; Miskowiak, Kamilla W.; Köhler, Cristiano A.; Maes, Michael; Fernandes, Brisa S.; Berk, Michael; Carvalho, André F. Cognitive remission: a novel objective for the treatment of major depression?. BMC Medicine. 22 January 2016, 14 (1): 9. ISSN 1741-7015. PMC 4724131 . PMID 26801406. doi:10.1186/s12916-016-0560-3.
- ^ Ooi, Soo Liang; Green, Ruth; Pak, Sok Cheon. N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence. BioMed Research International. 22 October 2018, 2018: e2469486. ISSN 2314-6133. PMC 6217900 . PMID 30426004. doi:10.1155/2018/2469486 （英语）.
- ^ Nery, Fabiano G.; Li, Wenbin; DelBello, Melissa P.; Welge, Jeffrey A. N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials. Bipolar Disorders. 15 January 2021, 23 (7): 707–714. ISSN 1398-5647. PMID 33354859. S2CID 229692736. doi:10.1111/bdi.13039.
- ^ Colpo, Gabriela D.; Leboyer, Marion; Dantzer, Robert; Trivedi, Mahdukar H.; Teixeira, Antonio L. Immune-based strategies for mood disorders: facts and challenges. Expert Review of Neurotherapeutics. 1 February 2018, 18 (2): 139–152. ISSN 1473-7175. PMC 5819337 . PMID 29179585. doi:10.1080/14737175.2018.1407242.
- ^ Fernandes, Brisa S.; Dean, Olivia M.; Dodd, Seetal; Malhi, Gin S.; Berk, Michael. N-Acetylcysteine in Depressive Symptoms and Functionality: A Systematic Review and Meta-Analysis. The Journal of Clinical Psychiatry. 27 April 2016, 77 (4): e457–66. ISSN 0160-6689. PMID 27137430. S2CID 40688371. doi:10.4088/JCP.15r09984 （English）.
- ^ "Modafinil"[Title/Abstract] - Search Results - PubMed. PubMed. [13 March 2023] （英语）.
- ^ Woolf, Nicky. Silk Road sentencing: why governments can't win the war on darknet drugs. The Guardian. 31 May 2015 [30 December 2016]. （原始内容存档于2019-04-13）.
- ^ Valette, Jean-Jacques. Du commerce illicite à la liberté d'expression totale, on a plongé dans le darknet. We Demain. 9 September 2016 [30 December 2016]. （原始内容存档于2016-12-30）.
- ^ ("enhance"[Title/Abstract] AND "cognition"[Title/Abstract]) OR ("neuroenhancement"[Title/Abstract]) OR ("cognitive enhancement"[Title/Abstract]) - Search Results - PubMed. PubMed. [13 March 2023] （英语）.
- ^ Hara, Y.; McKeehan, N.; Dacks, P. A.; Fillit, H. M. Evaluation of the neuroprotective potential of n-acetylcysteine for prevention and treatment of cognitive aging and dementia. Journal of Prevention of Alzheimer's Disease. 1 September 2017,. J Prev Alz Dis 20174 (3): 201–206. PMID 29182711. S2CID 45647979. doi:10.14283/jpad.2017.22.
- ^ Zhao, Danyue; Simon, James E.; Wu, Qingli. A critical review on grape polyphenols for neuroprotection: Strategies to enhance bioefficacy. Critical Reviews in Food Science and Nutrition. 21 February 2020, 60 (4): 597–625. ISSN 1040-8398. PMID 30614258. S2CID 58598405. doi:10.1080/10408398.2018.1546668.
- ^ 77.0 77.1 77.2 77.3 77.4 77.5 77.6 Onaolapo, Adejoke Yetunde; Obelawo, Adebimpe Yemisi; Onaolapo, Olakunle James. Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline. Current Aging Science. 2019, 12 (1): 2–14. PMC 6971896 . PMID 30864515. doi:10.2174/1874609812666190311160754 （英语）.
- ^ Ali, Fahad; Naz, Falaq; Jyoti, Smita; Siddique, Yasir Hasan. Health functionality of apigenin: A review. International Journal of Food Properties. 3 June 2017, 20 (6): 1197–1238. ISSN 1094-2912. S2CID 88642353. doi:10.1080/10942912.2016.1207188 （英语）.
- ^ Bonferoni, Maria Cristina; Rossi, Silvia; Sandri, Giuseppina; Ferrari, Franca; Gavini, Elisabetta; Rassu, Giovanna; Giunchedi, Paolo. Nanoemulsions for "Nose-to-Brain" Drug Delivery. Pharmaceutics. February 2019, 11 (2): 84. ISSN 1999-4923. PMC 6409749 . PMID 30781585. doi:10.3390/pharmaceutics11020084 （英语）.
- ^ Kaurav, Hemlata; Kapoor, Deepak N. Implantable systems for drug delivery to the brain. Therapeutic Delivery. December 2017, 8 (12): 1097–1107. PMID 29125063. doi:10.4155/tde-2017-0082.
- ^ 81.0 81.1 81.2 Darwish, Mona; Kirby, Mary; Hellriegel, Edward T.; Robertson, Philmore. Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives. Clinical Drug Investigation. 1 September 2009, 29 (9): 613–623. ISSN 1179-1918. PMID 19663523. S2CID 6607186. doi:10.2165/11315280-000000000-00000 （英语）.
- ^ 82.0 82.1 Sheng, Ping; Hou, Lijun; Wang, Xiang; Wang, Xiaowen; Huang, Chengguang; Yu, Mingkun; Han, Xi; Dong, Yan. Efficacy of Modafinil on Fatigue and Excessive Daytime Sleepiness Associated with Neurological Disorders: A Systematic Review and Meta-Analysis. PLOS ONE. 3 December 2013, 8 (12): e81802. Bibcode:2013PLoSO...881802S. PMC 3849275 . PMID 24312590. doi:10.1371/journal.pone.0081802 .
- ^ Darwish, Mona; Kirby, Mary; Hellriegel, Edward T.; Yang, Ronghua; Robertson, Philmore. Pharmacokinetic Profile of Armodafinil in Healthy Subjects. Clinical Drug Investigation. 1 February 2009, 29 (2): 87–100. ISSN 1179-1918. PMID 19133704. S2CID 24886727. doi:10.2165/0044011-200929020-00003 （英语）.
- ^ Getting smart to cognitive enhancers. eClinicalMedicine. 1 May 2019, 11: 1–2. ISSN 2589-5370. PMC 6610764 . PMID 31312801. S2CID 196810318. doi:10.1016/j.eclinm.2019.06.014 （English）.
- ^ 85.0 85.1 85.2 85.3 85.4 85.5 85.6 Malík, Matěj; Tlustoš, Pavel. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. Nutrients. January 2022, 14 (16): 3367. ISSN 2072-6643. PMC 9415189 . PMID 36014874. doi:10.3390/nu14163367 （英语）.
- ^ Lynch, Gary. Pharmacological enhancement of memory or cognition in normal subjects. Frontiers in Systems Neuroscience (Frontiers Media SA). 2014, 8. ISSN 1662-5137. doi:10.3389/fnsys.2014.00090.
- ^ 87.0 87.1 Fernstrom, John D.; Fernstrom, Madelyn H. Tyrosine, Phenylalanine, and Catecholamine Synthesis and Function in the Brain. The Journal of Nutrition. 1 June 2007, 137 (6): S1539–S1547. ISSN 0022-3166. PMID 17513421. doi:10.1093/jn/137.6.1539S （英语）.
- ^ Riedel, Wim J; Klaassen, Tineke; Schmitt, Jeroen A. J. Tryptophan, mood, and cognitive function. Brain, Behavior, and Immunity. 1 October 2002, 16 (5): 581–589. ISSN 0889-1591. PMID 12401472. S2CID 42931109. doi:10.1016/S0889-1591(02)00013-2 （英语）.
[...] As noted above two experiments addressed the question how [acute tryptophan depletion (ATD)] affects cognitive functions in healthy individuals. These experiments shared one common dependent variable, which was the memory task. In the first study it was shown that ATD impaired long-term memory consolidation when a new word list was learned at 6 h after start of depletion [...]
- ^ 89.0 89.1 Camfield, David A; Stough, Con; Farrimond, Jonathon; Scholey, Andrew B. Acute effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis. Nutrition Reviews. August 2014, 72 (8): 507–522. PMID 24946991. doi:10.1111/nure.12120.
- ^ 90.0 90.1 Sohail, Anas Anas; Ortiz, Fernando; Varghese, Teresa; Fabara, Stephanie P.; Batth, Arshdeep S.; Sandesara, Darshan P.; Sabir, Ahtesham; Khurana, Mahika; Datta, Shae; Patel, Urvish K.; Sohail, Anas Anas; Ortiz, Juan Fernando; Varghese, Teresa; Fabara, Stephanie P.; Batth, Arshdeep S.; Sandesara, Darshan P.; Sabir, Ahtesham; Khurana, Mahika; Datta, Shae; Patel, Urvish K. The Cognitive-Enhancing Outcomes of Caffeine and L-theanine: A Systematic Review. Cureus. 30 December 2021, 13 (12): e20828. ISSN 2168-8184. PMC 8794723 . PMID 35111479. doi:10.7759/cureus.20828 （英语）.
- ^ 91.0 91.1 91.2 91.3 91.4 Meeusen, Romain; Decroix, Lieselot. Nutritional Supplements and the Brain. International Journal of Sport Nutrition and Exercise Metabolism. 1 March 2018, 28 (2): 200–211. ISSN 1543-2742. PMID 29252056. S2CID 4582295. doi:10.1123/ijsnem.2017-0314 （英语）.
- ^ Gunzelmann, Glenn; M. James, Stephen; Caldwell, Jo Lynn. Basic and applied science interactions in fatigue understanding and risk mitigation. Chapter 8 - Basic and applied science interactions in fatigue understanding and risk mitigation. Progress in Brain Research 246. Elsevier. 1 January 2019: 177–204. ISBN 9780444642509. PMID 31072561. S2CID 145885926. doi:10.1016/bs.pbr.2019.03.022 （英语）.
- ^ Young, Allan H. 'Memory, hither come': Psychopharmacology of memory and more. Journal of Psychopharmacology. June 2021, 35 (6): 619–620 [2023-08-16]. ISSN 0269-8811. PMID 34039101. S2CID 235217295. doi:10.1177/02698811211021065. （原始内容存档于2023-04-18） （英语）.
- ^ Gonzalez, Natalie A.; Sakhamuri, Navya; Athiyaman, Sreekartthik; Randhi, Bhawna; Gutlapalli, Sai Dheeraj; Pu, Jingxiong; Zaidi, Maheen F.; Patel, Maithily; Atluri, Lakshmi Malvika; Franchini, Ana P. Arcia; Gonzalez, Natalie A.; Sakhamuri, Navya; Athiyaman, Sreekartthik; Randhi, Bhawna; Gutlapalli, Sai Dheeraj; Pu, Jingxiong; Zaidi, Maheen F.; Patel, Maithily; Atluri, Lakshmi Malvika; Franchini, Ana P. Arcia. A Systematic Review of Yoga and Meditation for Attention-Deficit/Hyperactivity Disorder in Children. Cureus. 14 March 2023, 15 (3): e36143. ISSN 2168-8184. PMC 10101238 . PMID 37065343. S2CID 257541572. doi:10.7759/cureus.36143 （英语）.
- ^ Baumel, Barry S.; Doraiswamy, P. Murali; Sabbagh, Marwan; Wurtman, Richard. Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review. Neurology and Therapy. 1 June 2021, 10 (1): 43–60. ISSN 2193-6536. PMC 8139993 . PMID 33368017. doi:10.1007/s40120-020-00227-y （英语）.
- ^ Wurtman, Richard J; Cansev, Mehmet; Sakamoto, Toshimasa; Ulus, Ismael. Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses: Nutrition Reviews, Vol. 68, No. s2. Nutrition Reviews. December 2010, 68 (Suppl 2): S88–S101. PMC 3062998 . PMID 21091953. doi:10.1111/j.1753-4887.2010.00344.x.
- ^ 97.0 97.1 Cardoso, Carlos; Afonso, Cláudia; Bandarra, Narcisa M. Dietary DHA and health: cognitive function ageing. Nutrition Research Reviews. December 2016, 29 (2): 281–294. ISSN 0954-4224. PMID 27866493. S2CID 4243219. doi:10.1017/S0954422416000184 （英语）.
- ^ 98.0 98.1 98.2 98.3 Van Puyvelde, Martine; Van Cutsem, Jeroen; Lacroix, Emilie; Pattyn, Nathalie. A State-of-the-Art Review on the Use of Modafinil as A Performance-enhancing Drug in the Context of Military Operationality. Military Medicine. 11 October 2021, 187 (11–12): 1286–1298. ISSN 0026-4075. PMID 34632515. doi:10.1093/milmed/usab398.
- ^ 99.0 99.1 99.2 Mohamed, Ahmed Dahir. Neuroethical issues in pharmacological cognitive enhancement. WIREs Cognitive Science (Wiley). 2014-07-28, 5 (5): 533–549. ISSN 1939-5078. doi:10.1002/wcs.1306.
- ^ 100.0 100.1 100.2 100.3 Sousa, Ana; Dinis-Oliveira, Ricardo Jorge. Pharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects. Substance Abuse. 2 April 2020, 41 (2): 155–173. ISSN 0889-7077. PMID 31951804. S2CID 210709160. doi:10.1080/08897077.2019.1700584.
- ^ Minzenberg, Michael J; Carter, Cameron S. Modafinil: A Review of Neurochemical Actions and Effects on Cognition. Neuropsychopharmacology. June 2008, 33 (7): 1477–1502. PMID 17712350. S2CID 13752498. doi:10.1038/sj.npp.1301534.
- ^ Hofmann, Stefan G.; Mundy, Elizabeth A.; Curtiss, Joshua; Hofmann, Stefan G.; Mundy, Elizabeth A.; Curtiss, Joshua. Neuroenhancement of Exposure Therapy in Anxiety Disorders. AIMS Neuroscience. 2015, 2 (3): 123–138. PMC 4545667 . PMID 26306326. doi:10.3934/Neuroscience.2015.3.123.
- ^ Zager, Adriano. Modulating the immune response with the wake-promoting drug modafinil: A potential therapeutic approach for inflammatory disorders. Brain, Behavior, and Immunity. 1 August 2020, 88: 878–886. ISSN 0889-1591. PMID 32311496. S2CID 215807973. doi:10.1016/j.bbi.2020.04.038 （英语）.
- ^ Heilman, Kenneth M. Possible Brain Mechanisms of Creativity. Archives of Clinical Neuropsychology (Oxford University Press (OUP)). 2016-03-21, 31 (4): 285–296. ISSN 0887-6177. doi:10.1093/arclin/acw009.
- ^ 105.0 105.1 105.2 Tennison, Michael N.; Moreno, Jonathan D. Neuroenhancement and Therapy in National Defense Contexts. The Routledge Handbook of Neuroethics.
- ^ Genetically modified neurons could help us connect to implants. New Scientist. [1 February 2022]. （原始内容存档于2023-05-28）.
- ^ Scientists program cells to carry out gene-guided construction projects. phys.org. [5 April 2020]. （原始内容存档于2023-04-08） （美国英语）.
- ^ Otto, Kevin J.; Schmidt, Christine E. Neuron-targeted electrical modulation. Science. 20 March 2020, 367 (6484): 1303–1304. Bibcode:2020Sci...367.1303O. PMID 32193309. S2CID 213192749. doi:10.1126/science.abb0216.
- ^ Liu, Jia; Kim, Yoon Seok; Richardson, Claire E.; Tom, Ariane; Ramakrishnan, Charu; Birey, Fikri; Katsumata, Toru; Chen, Shucheng; Wang, Cheng; Wang, Xiao; Joubert, Lydia-Marie; Jiang, Yuanwen; Wang, Huiliang; Fenno, Lief E.; Tok, Jeffrey B.-H.; Pașca, Sergiu P.; Shen, Kang; Bao, Zhenan; Deisseroth, Karl. Genetically targeted chemical assembly of functional materials in living cells, tissues, and animals. Science. 20 March 2020, 367 (6484): 1372–1376. Bibcode:2020Sci...367.1372L. PMC 7527276 . PMID 32193327. S2CID 213191980. doi:10.1126/science.aay4866.
- ^ Bolakhe, Saugat. Lego Robot with an Organic 'Brain' Learns to Navigate a Maze. Scientific American. [1 February 2022]. （原始内容存档于2023-04-08） （英语）.
- ^ Sample, Ian. Bionic neurons could enable implants to restore failing brain circuits. The Guardian. 3 December 2019 [27 February 2023]. （原始内容存档于2023-04-08）.
- ^ Abu-Hassan, Kamal; Taylor, Joseph D.; Morris, Paul G.; Donati, Elisa; Bortolotto, Zuner A.; Indiveri, Giacomo; Paton, Julian F. R.; Nogaret, Alain. Optimal solid state neurons. Nature Communications. 3 December 2019, 10 (1): 5309. Bibcode:2019NatCo..10.5309A. ISSN 2041-1723. PMC 6890780 . PMID 31796727. doi:10.1038/s41467-019-13177-3 （英语）.
- ^ 113.0 113.1 Buchanan, Allen. Cognitive enhancement and education. Theory and Research in Education. July 2011, 9 (2): 145–162. ISSN 1477-8785. S2CID 145441073. doi:10.1177/1477878511409623 （英语）.
- ^ Nakhaee, Samaneh; Kooshki, Alireza; Hormozi, Ali; Akbari, Aref; Mehrpour, Omid; Farrokhfall, Khadijeh. Cinnamon and cognitive function: a systematic review of preclinical and clinical studies. Nutritional Neuroscience. 18 January 2023: 1–15. ISSN 1028-415X. PMID 36652384. S2CID 255969320. doi:10.1080/1028415X.2023.2166436.
- ^ Gratton, Gabriele; Weaver, Samuel R.; Burley, Claire V.; Low, Kathy A.; Maclin, Edward L.; Johns, Paul W.; Pham, Quang S.; Lucas, Samuel J. E.; Fabiani, Monica; Rendeiro, Catarina. Dietary flavanols improve cerebral cortical oxygenation and cognition in healthy adults. Scientific Reports. 24 November 2020, 10 (1): 19409. Bibcode:2020NatSR..1019409G. ISSN 2045-2322. PMC 7687895 . PMID 33235219. doi:10.1038/s41598-020-76160-9 （英语）.
- ^ Melzer, Thayza Martins; Manosso, Luana Meller; Yau, Suk-yu; Gil-Mohapel, Joana; Brocardo, Patricia S. In Pursuit of Healthy Aging: Effects of Nutrition on Brain Function. International Journal of Molecular Sciences. January 2021, 22 (9): 5026. ISSN 1422-0067. PMC 8126018 . PMID 34068525. doi:10.3390/ijms22095026 （英语）.
- ^ 117.0 117.1 Socci, Valentina; Tempesta, Daniela; Desideri, Giovambattista; De Gennaro, Luigi; Ferrara, Michele. Enhancing Human Cognition with Cocoa Flavonoids. Frontiers in Nutrition. 2017, 4: 19. ISSN 2296-861X. PMC 5432604 . PMID 28560212. doi:10.3389/fnut.2017.00019 .
- ^ Kent, K.; Charlton, K. E.; Netzel, M.; Fanning, K. Food-based anthocyanin intake and cognitive outcomes in human intervention trials: a systematic review. Journal of Human Nutrition and Dietetics. June 2017, 30 (3): 260–274. PMID 27730693. S2CID 4344504. doi:10.1111/jhn.12431 （英语）.
- ^ Zamri, Nurul Ashykin; Ghani, Nurhafizah; Ismail, Che Aishah Nazariah; Zakaria, Rahimah; Shafin, Nazlahshaniza. Honey on brain health: A promising brain booster. Frontiers in Aging Neuroscience. 2023, 14. ISSN 1663-4365. PMC 9887050 . PMID 36733498. doi:10.3389/fnagi.2022.1092596 .
- ^ Kennedy, David O. Polyphenols and the Human Brain: Plant "Secondary Metabolite" Ecologic Roles and Endogenous Signaling Functions Drive Benefits. Advances in Nutrition. 1 September 2014, 5 (5): 515–533. ISSN 2161-8313. PMC 4188223 . PMID 25469384. doi:10.3945/an.114.006320 （英语）.
- ^ Gomez-Pinilla, Fernando; Nguyen, Trang T J. Natural mood foods: The actions of polyphenols against psychiatric and cognitive disorders. Nutritional Neuroscience. 1 May 2012, 15 (3): 127–133. ISSN 1028-415X. PMC 3355196 . PMID 22334236. doi:10.1179/1476830511Y.0000000035.
- ^ Vauzour, David; Rodriguez-Mateos, Ana; Corona, Giulia; Oruna-Concha, Maria Jose; Spencer, Jeremy P. E. Polyphenols and Human Health: Prevention of Disease and Mechanisms of Action. Nutrients. November 2010, 2 (11): 1106–1131. ISSN 2072-6643. PMC 3257622 . PMID 22254000. doi:10.3390/nu2111106 （英语）.
- ^ Guerrieri, Davide; Moon, Hyo Youl; van Praag, Henriette. Exercise in a Pill: The Latest on Exercise-Mimetics. Brain Plasticity. 1 January 2017, 2 (2): 153–169. ISSN 2213-6304. PMC 5928571 . PMID 29765854. doi:10.3233/BPL-160043 （英语）.
- ^ Haskell-Ramsay, Crystal F.; Schmitt, Jeroen; Actis-Goretta, Lucas. The Impact of Epicatechin on Human Cognition: The Role of Cerebral Blood Flow. Nutrients. August 2018, 10 (8): 986. ISSN 2072-6643. PMC 6115745 . PMID 30060538. doi:10.3390/nu10080986 （英语）.
- ^ Strasser, Barbara; Gostner, Johanna M.; Fuchs, Dietmar. Mood, food, and cognition: role of tryptophan and serotonin
. Current Opinion in Clinical Nutrition and Metabolic Care. January 2016, 19 (1): 55–61 [2023-08-16]. PMID 26560523. S2CID 12387611. doi:10.1097/MCO.0000000000000237. （原始内容存档于2023-06-06）.
- ^ 126.0 126.1 126.2 126.3 126.4 126.5 126.6 Pranav, Joshi C. A review on natural memory enhancers (nootropics) (PDF). Unique Journal of Engineering and Advanced Sciences. 2013 [2023-08-16]. （原始内容存档 (PDF)于2023-04-08） （英语）.
- ^ Jongkees, Bryant J.; Hommel, Bernhard; Kühn, Simone; Colzato, Lorenza S. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands—A review. Journal of Psychiatric Research. 1 November 2015, 70: 50–57. ISSN 0022-3956. PMID 26424423. doi:10.1016/j.jpsychires.2015.08.014 （英语）.
- ^ 128.0 128.1 128.2 McCarthy, Bozena; O'Neill, Graham; Abu-Ghannam, Nissreen. Potential Psychoactive Effects of Microalgal Bioactive Compounds for the Case of Sleep and Mood Regulation: Opportunities and Challenges. Marine Drugs. August 2022, 20 (8): 493. ISSN 1660-3397. PMC 9410000 . PMID 36005495. doi:10.3390/md20080493 （英语）.
- ^ Lee, Gihyun; Bae, Hyunsu. Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression. BioMed Research International. 2017, 2017: 1–11. PMC 5414506 . PMID 28503571. doi:10.1155/2017/6596241 .
- ^ Venigalla, Madhuri; Gyengesi, Erika; Münch, Gerald. Curcumin and Apigenin – novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease. Neural Regeneration Research. August 2015, 10 (8): 1181–1185. ISSN 1673-5374. PMC 4590215 . PMID 26487830. doi:10.4103/1673-5374.162686.
- ^ Salehi, Bahare; Venditti, Alessandro; Sharifi-Rad, Mehdi; Kręgiel, Dorota; Sharifi-Rad, Javad; Durazzo, Alessandra; Lucarini, Massimo; Santini, Antonello; Souto, Eliana B.; Novellino, Ettore; Antolak, Hubert; Azzini, Elena; Setzer, William N.; Martins, Natália. The Therapeutic Potential of Apigenin. International Journal of Molecular Sciences. January 2019, 20 (6): 1305. ISSN 1422-0067. PMC 6472148 . PMID 30875872. doi:10.3390/ijms20061305 （英语）.
- ^ Arcusa, Raúl; Villaño, Débora; Marhuenda, Javier; Cano, Miguel; Cerdà, Begoña; Zafrilla, Pilar. Potential Role of Ginger (Zingiber officinale Roscoe) in the Prevention of Neurodegenerative Diseases. Frontiers in Nutrition. 2022, 9: 809621. ISSN 2296-861X. PMC 8971783 . PMID 35369082. doi:10.3389/fnut.2022.809621 .
- ^ Etheridge, Christopher John; Derbyshire, Emma. Herbal infusions and health: A review of findings from human studies, mechanisms and future research directions. Nutrition & Food Science. 1 January 2020, 50 (5): 969–985. ISSN 0034-6659. S2CID 211002387. doi:10.1108/NFS-08-2019-0263.
- ^ Howes, Melanie-Jayne R.; Perry, Nicolette S.L.; Vásquez-Londoño, Carlos; Perry, Elaine K. Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing. British Journal of Pharmacology. March 2020, 177 (6): 1294–1315. ISSN 0007-1188. PMC 7056459 . PMID 31650528. doi:10.1111/bph.14898 （英语）.
- ^ Roe, Amy L.; Venkataraman, Arvind. The Safety and Efficacy of Botanicals with Nootropic Effects. Current Neuropharmacology. September 2021, 19 (9): 1442–1467. PMC 8762178 . PMID 34315377. doi:10.2174/1570159X19666210726150432.
- ^ Hussain, S. M.; Syeda, A. F.; Alshammari, M.; Alnasser, S.; Alenzi, N. D.; Alanazi, S. T.; Nandakumar, K. Cognition enhancing effect of rosemary (Rosmarinus officinalis L.) in lab animal studies: a systematic review and meta-analysis. Brazilian Journal of Medical and Biological Research. 9 February 2022, 55: e11593. ISSN 0100-879X. PMC 8851910 . PMID 35170682. doi:10.1590/1414-431X2021e11593 （英语）.
- ^ 137.0 137.1 Lewis, John E.; Poles, Jillian; Shaw, Delaney P.; Karhu, Elisa; Khan, Sher Ali; Lyons, Annabel E.; Sacco, Susana Barreiro; McDaniel, H. Reginald. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. Journal of Clinical and Translational Research. 26 August 2021, 7 (4): 575–620. ISSN 2424-810X. PMC 8445631 . PMID 34541370. doi:10.18053/jctres.07.202104.014.
- ^ Suliman, Noor Azuin; Mat Taib, Che Norma; Mohd Moklas, Mohamad Aris; Adenan, Mohd Ilham; Hidayat Baharuldin, Mohamad Taufik; Basir, Rusliza. Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evidence-Based Complementary and Alternative Medicine. 30 August 2016, 2016: e4391375. ISSN 1741-427X. PMC 5021479 . PMID 27656235. doi:10.1155/2016/4391375 （英语）.
- ^ Roschel, Hamilton; Gualano, Bruno; Ostojic, Sergej M.; Rawson, Eric S. Creatine Supplementation and Brain Health. Nutrients. February 2021, 13 (2): 586. ISSN 2072-6643. PMC 7916590 . PMID 33578876. doi:10.3390/nu13020586 （英语）.
- ^ Dolan, Eimear; Gualano, Bruno; Rawson, Eric S. Beyond muscle: the effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury. European Journal of Sport Science. 2 January 2019, 19 (1): 1–14. ISSN 1746-1391. PMID 30086660. S2CID 51936612. doi:10.1080/17461391.2018.1500644.
- ^ 141.0 141.1 Crawford, Cindy; Boyd, Courtney; Deuster, Patricia A. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. The Journal of Alternative and Complementary Medicine. 1 November 2021, 27 (11): 940–958. ISSN 1075-5535. PMID 34370563. S2CID 236969310. doi:10.1089/acm.2021.0135.
- ^ Dyall, Simon C. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in Aging Neuroscience. 2015, 7: 52. ISSN 1663-4365. PMC 4404917 . PMID 25954194. doi:10.3389/fnagi.2015.00052 .
- ^ Singh, Jessica E. Dietary Sources of Omega-3 Fatty Acids Versus Omega-3 Fatty Acid Supplementation Effects on Cognition and Inflammation. Current Nutrition Reports. 1 September 2020, 9 (3): 264–277. ISSN 2161-3311. PMID 32621236. S2CID 220306807. doi:10.1007/s13668-020-00329-x （英语）.
- ^ Fadó, Rut; Molins, Anna; Rojas, Rocío; Casals, Núria. Feeding the Brain: Effect of Nutrients on Cognition, Synaptic Function, and AMPA Receptors. Nutrients. January 2022, 14 (19): 4137. ISSN 2072-6643. PMC 9572450 . PMID 36235789. doi:10.3390/nu14194137 （英语）.
- ^ Weiser, Michael; Butt, Christopher; Mohajeri, M. Docosahexaenoic Acid and Cognition throughout the Lifespan. Nutrients (MDPI AG). 2016-02-17, 8 (2): 99. ISSN 2072-6643. doi:10.3390/nu8020099.
- ^ [142][143][128][144][145][97] and other nutrients and phytonutrients[137][141]
- ^ Muscaritoli, Maurizio. The Impact of Nutrients on Mental Health and Well-Being: Insights From the Literature. Frontiers in Nutrition. 2021, 8: 656290. ISSN 2296-861X. PMC 7982519 . PMID 33763446. doi:10.3389/fnut.2021.656290 .
- ^ Venkatramanan, Sudha; Armata, Ilianna E; Strupp, Barbara J; Finkelstein, Julia L. Vitamin B-12 and Cognition in Children. Advances in Nutrition. 1 September 2016, 7 (5): 879–888. ISSN 2161-8313. PMC 5015033 . PMID 27633104. doi:10.3945/an.115.012021 （英语）.
Despite the high prevalence of vitamin B-12 insufficiency and associated risk of adverse cognitive outcomes in children, to our knowledge, no studies to date have been conducted to examine the effects of vitamin B-12 supplementation on cognition in children.
- ^ Benton, David. To establish the parameters of optimal nutrition do we need to consider psychological in addition to physiological parameters?. Molecular Nutrition & Food Research. January 2013, 57 (1): 6–19. PMID 23038656. doi:10.1002/mnfr.201200477 （英语）.
The decarboyxlase enzymes have pyridoxal phosphate as a coenzyme, the form in which vitamin B6 occurs most commonly in the diet. Yet there is evidence of marginal intakes of this vitamin: e.g. using a biochemical measure of pyridoxal phosphate status there was a subgroup of about 10% of British school children who were deficient [89]. In young British adults 27.7% of males and 36.6% of females were deficient as judged by the same measure
- ^ Stevens, Gretchen A.; Beal, Ty; Mbuya, Mduduzi N. N.; Luo, Hanqi; Neufeld, Lynnette M.; Addo, O. Yaw; Adu-Afarwuah, Seth; Alayón, Silvia; Bhutta, Zulfiqar; Brown, Kenneth H.; Jefferds, Maria Elena; Engle-Stone, Reina; Fawzi, Wafaie; Hess, Sonja Y.; Johnston, Robert; Katz, Joanne; Krasevec, Julia; McDonald, Christine M.; Mei, Zuguo; Osendarp, Saskia; Paciorek, Christopher J.; Petry, Nicolai; Pfeiffer, Christine M.; Ramirez-Luzuriaga, Maria J.; Rogers, Lisa M.; Rohner, Fabian; Sethi, Vani; Suchdev, Parminder S.; Tessema, Masresha; Villapando, Salvador; Wieringa, Frank T.; Williams, Anne M.; Woldeyahannes, Meseret; Young, Melissa F. Micronutrient deficiencies among preschool-aged children and women of reproductive age worldwide: a pooled analysis of individual-level data from population-representative surveys. The Lancet Global Health. 1 November 2022, 10 (11): e1590–e1599. ISSN 2214-109X. PMID 36240826. S2CID 252857990. doi:10.1016/S2214-109X(22)00367-9 （English）.
- ^ Enderami, Athena; Zarghami, Mehran; Darvishi-Khezri, Hadi. The effects and potential mechanisms of folic acid on cognitive function: a comprehensive review. Neurological Sciences. 1 October 2018, 39 (10): 1667–1675. ISSN 1590-3478. PMID 29936555. S2CID 49421574. doi:10.1007/s10072-018-3473-4 （英语）.
- ^ Philippou, Elena; Constantinou, Marios. The Influence of Glycemic Index on Cognitive Functioning: A Systematic Review of the Evidence. Advances in Nutrition. 1 March 2014, 5 (2): 119–130. ISSN 2161-8313. PMC 3951795 . PMID 24618754. doi:10.3945/an.113.004960 （英语）.
- ^ Rebelos, Eleni; Rinne, Juha O.; Nuutila, Pirjo; Ekblad, Laura L. Brain Glucose Metabolism in Health, Obesity, and Cognitive Decline—Does Insulin Have Anything to Do with It? A Narrative Review. Journal of Clinical Medicine. January 2021, 10 (7): 1532. ISSN 2077-0383. PMC 8038699 . PMID 33917464. doi:10.3390/jcm10071532 （英语）.
- ^ Gubert, Carolina; Hannan, Anthony J. Exercise mimetics: harnessing the therapeutic effects of physical activity. Nature Reviews Drug Discovery. November 2021, 20 (11): 862–879. ISSN 1474-1784. PMID 34103713. S2CID 235379365. doi:10.1038/s41573-021-00217-1 （英语）.
- ^ Yamada, Yujiro; Frith, Emily M.; Wong, Vickie; Spitz, Robert W.; Bell, Zachary W.; Chatakondi, Raksha N.; Abe, Takashi; Loenneke, Jeremy P. Acute exercise and cognition: A review with testable questions for future research into cognitive enhancement with blood flow restriction. Medical Hypotheses. 1 June 2021, 151: 110586. ISSN 0306-9877. PMID 33848917. S2CID 233233538. doi:10.1016/j.mehy.2021.110586 （英语）.
- ^ Taubert, Marco; Villringer, Arno; Lehmann, Nico. Endurance Exercise as an "Endogenous" Neuro-enhancement Strategy to Facilitate Motor Learning. Frontiers in Human Neuroscience. 2015, 9: 692. ISSN 1662-5161. PMC 4714627 . PMID 26834602. doi:10.3389/fnhum.2015.00692 .
- ^ 157.0 157.1 157.2 Tennison, Michael N.; Moreno, Jonathan D. Neuroscience、 Ethics、 and National Security: The State of the Art. PLOS Biology. 20 March 2012, 10 (3): e1001289. ISSN 1545-7885. PMC 3308927 . PMID 22448146. doi:10.1371/journal.pbio.1001289 （英语）.
- ^ Asua, Diego; Bougamra, Ghassen; Calleja-Felipe, María; Morales, Miguel; Knafo, Shira. Peptides Acting as Cognitive Enhancers. Neuroscience. 1 February 2018, 370: 81–87. ISSN 0306-4522. PMID 29030286. S2CID 10269993. doi:10.1016/j.neuroscience.2017.10.002 （英语）.
- ^ Wright, John W.; Harding, Joseph W. The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease. 1 January 2015, 45 (4): 985–1000. ISSN 1387-2877. PMID 25649658. doi:10.3233/JAD-142814 （英语）.
- ^ Ho, Jean K.; Nation, Daniel A. Cognitive benefits of angiotensin IV and angiotensin-(1–7): A systematic review of experimental studies. Neuroscience & Biobehavioral Reviews. 1 September 2018, 92: 209–225. ISSN 0149-7634. PMC 8916541 . PMID 29733881. doi:10.1016/j.neubiorev.2018.05.005 （英语）.
- ^ Hallberg, Mathias; Larhed, Mats. From Angiotensin IV to Small Peptidemimetics Inhibiting Insulin-Regulated Aminopeptidase. Frontiers in Pharmacology. 2020, 11: 590855. ISSN 1663-9812. PMC 7593869 . PMID 33178027. doi:10.3389/fphar.2020.590855 .
- ^ Stern, Sarah A.; Alberini, Cristina M. Mechanisms of memory enhancement. WIREs Systems Biology and Medicine. January 2013, 5 (1): 37–53. ISSN 1939-5094. PMC 3527655 . PMID 23151999. doi:10.1002/wsbm.1196 （英语）.
- ^ Hofmann, Stefan G.; Fang, Angela; Gutner, Cassidy A. Cognitive enhancers for the treatment of anxiety disorders. Restorative Neurology and Neuroscience. 1 January 2014, 32 (1): 183–195. ISSN 0922-6028. PMID 23542909. doi:10.3233/RNN-139002 （英语）.
- ^ Diekelmann, Susanne. Sleep for cognitive enhancement. Frontiers in Systems Neuroscience. 2014, 8: 46. ISSN 1662-5137. PMC 3980112 . PMID 24765066. doi:10.3389/fnsys.2014.00046 .
- ^ Merlo, Emiliano; Milton, Amy L; Everitt, Barry J. Enhancing cognition by affecting memory reconsolidation (PDF). Current Opinion in Behavioral Sciences. 1 August 2015, 4: 41–47 [2023-08-16]. ISSN 2352-1546. S2CID 53170506. doi:10.1016/j.cobeha.2015.02.003. （原始内容存档 (PDF)于2023-05-16） （英语）.
- ^ Desibhatla, Mukund. The Development and Evaluation of Novel DA Transport Inhibitors and their Effects on Effort-Related Motivation: A Review. Honors Scholar Theses. 1 May 2021 [2023-08-16]. （原始内容存档于2023-04-08）.
- ^ Froestl, Wolfgang; Muhs, Andreas; Pfeifer, Andrea. Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors. Journal of Alzheimer's Disease. 1 January 2012, 32 (4): 793–887. ISSN 1387-2877. PMID 22886028. doi:10.3233/JAD-2012-121186 （英语）.
- ^ Partin, Kathryn M. AMPA receptor potentiators: from drug design to cognitive enhancement. Current Opinion in Pharmacology. 1 February 2015, 20: 46–53. ISSN 1471-4892. PMC 4318786 . PMID 25462292. doi:10.1016/j.coph.2014.11.002 （英语）.
- ^ Þorsteinsson, Haraldur; Karlsson, KarlÆgir. Is Sleep Beyond Our Control?. The Open Sleep Journal. 12 August 2009, 2 (1): 48–55. doi:10.2174/1874620900902010048.
- ^ Kato, Taro; Duman, Ronald S. Rapastinel、 a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms. Pharmacology Biochemistry and Behavior. 1 January 2020, 188: 172827. ISSN 0091-3057. PMID 31733218. S2CID 207976034. doi:10.1016/j.pbb.2019.172827 （英语）.
- ^ Burgdorf, Jeffrey; Zhang, Xiao-lei; Weiss, Craig; Matthews, Elizabeth; Disterhoft, John F.; Stanton, Patric K.; Moskal, Joseph R. The N-methyl-d-aspartate receptor modulator GLYX-13 enhances learning and memory、 in young adult and learning impaired aging rats. Neurobiology of Aging. 1 April 2011, 32 (4): 698–706. ISSN 0197-4580. PMC 3035742 . PMID 19446371. doi:10.1016/j.neurobiolaging.2009.04.012 （英语）.
- ^ R. Moskal, Joseph; S. Burgdorf, Jeffrey; K. Stanton, Patric; A. Kroes, Roger; F. Disterhoft, John; M. Burch, Ronald; Amin Khan, M. The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant. Current Neuropharmacology. 2017, 15 (1): 47–56 [2023-08-16]. PMC 5327451 . PMID 26997507. doi:10.2174/1570159X14666160321122703. （原始内容存档于2023-04-08） （英语）.
- ^ Costa-Mattioli, Mauro; Walter, Peter. The integrated stress response: From mechanism to disease. Science. 24 April 2020, 368 (6489): eaat5314. ISSN 0036-8075. PMC 8997189 . PMID 32327570. doi:10.1126/science.aat5314 （英语）.
- ^ Jin, Yang; Saatcioglu, Fahri. Targeting the Unfolded Protein Response in Hormone-Regulated Cancers. Trends in Cancer. 1 February 2020, 6 (2): 160–171. ISSN 2405-8033. PMID 32061305. S2CID 211136354. doi:10.1016/j.trecan.2019.12.001 （英语）.
- ^ Tardner, P. The use of citicoline for the treatment of cognitive decline and cognitive impairment: A meta-analysis of pharmacological literature • International Journal of Environmental Science & Technology. International Journal of Environmental Science & Technology. 2020-08-30 [2020-08-31]. （原始内容存档于2023-06-03） （美国英语）.
- ^ Atack, John R. GABAA Receptor Subtype-Selective Modulators. II. α5-Selective Inverse Agonists for Cognition Enhancement. Current Topics in Medicinal Chemistry. 2011, 11 (9): 1203–1214. PMID 21050171. doi:10.2174/156802611795371314 （英语）.
- ^ Kleczkowska, Patrycja. Chimeric Structures in Mental Illnesses—"Magic" Molecules Specified for Complex Disorders. International Journal of Molecular Sciences. January 2022, 23 (7): 3739. ISSN 1422-0067. PMC 8998808 . PMID 35409098. doi:10.3390/ijms23073739 （英语）.
- ^ Sharma, Horrick; Santra, Soumava; Dutta, Aloke. Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?. Future Medicinal Chemistry. November 2015, 7 (17): 2385–2406. PMC 4976848 . PMID 26619226. doi:10.4155/fmc.15.134.
- ^ Subbaiah, Murugaiah A. M. Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges. Journal of Medicinal Chemistry. 22 March 2018, 61 (6): 2133–2165. ISSN 0022-2623. PMID 28731336. doi:10.1021/acs.jmedchem.6b01827 （英语）.
- ^ Jacobson, Laura H.; Hoyer, Daniel; Lecea, Luis. Hypocretins (orexins): The ultimate translational neuropeptides. Journal of Internal Medicine. May 2022, 291 (5): 533–556. ISSN 0954-6820. PMID 35043499. S2CID 248119793. doi:10.1111/joim.13406 （英语）.
- ^ Seigneur, Erica; de Lecea, Luis. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery. 1 December 2020, 8: 100070. ISSN 2590-0986. S2CID 225129746. doi:10.1016/j.medidd.2020.100070 （英语）.
- ^ 182.0 182.1 Alhusaini, Mera; Eissa, Nermin; Saad, Ali K.; Beiram, Rami; Sadek, Bassem. Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment、 Anxiety、 Depression、 and Sleep–Wake Cycle Disorder. Frontiers in Pharmacology. 2022, 13: 861094. ISSN 1663-9812. PMC 9198498 . PMID 35721194. doi:10.3389/fphar.2022.861094 .
- ^ Shinde, Anil; Subramanian, Ramkumar; Palacharla, Raghava; Benade, Vijay; Abraham, Renny; Kamuju, Venkatesh; Pandey, Santosh; Badange, Rajesh; Achanta, Pramod Kumar; Nirogi, Ramakrishna. 004 Samelisant (SUVN-G3031)、 Differentiating features over current treatments of narcolepsy. Sleep. 1 May 2021, 44 (Supplement_2): A2. ISSN 0161-8105. doi:10.1093/sleep/zsab072.003.
Recent research has described a procognitive effect of samelisant、 an inverse agonist of H3 receptors、 in animal models of schizophrenia [157]. Nevertheless、 more studies are required.
- ^ Poulose, Shibu M.; Thangthaeng, Nopporn; Miller, Marshall G.; Shukitt-Hale, Barbara. Effects of pterostilbene and resveratrol on brain and behavior. Neurochemistry International. 1 October 2015, 89: 227–233. ISSN 0197-0186. PMID 26212523. S2CID 33577543. doi:10.1016/j.neuint.2015.07.017 （英语）.
- ^ McCormack, Denise; McFadden, David. A Review of Pterostilbene Antioxidant Activity and Disease Modification. Oxidative Medicine and Cellular Longevity. 4 April 2013, 2013: e575482. ISSN 1942-0900. PMC 3649683 . PMID 23691264. doi:10.1155/2013/575482 （英语）.
- ^ Buntwal, Luke; Sassi, Martina; Morgan, Alwena H.; Andrews, Zane B.; Davies, Jeffrey S. Ghrelin-Mediated Hippocampal Neurogenesis: Implications for Health and Disease. Trends in Endocrinology & Metabolism. 1 November 2019, 30 (11): 844–859 [2023-08-16]. ISSN 1043-2760. PMID 31445747. S2CID 201126380. doi:10.1016/j.tem.2019.07.001. （原始内容存档于2023-04-17） （英语）.
- ^ Morgan, A. H.; Andrews, Z. B.; Davies, J. S. Less is more: Caloric regulation of neurogenesis and adult brain function. Journal of Neuroendocrinology. October 2017, 29 (10): e12512. PMID 28771924. S2CID 3070497. doi:10.1111/jne.12512 （英语）.
- ^ Harwell, Victoria; Fasinu, Pius. Pitolisant and Other Histamine-3 Receptor Antagonists—An Update on Therapeutic Potentials and Clinical Prospects. Medicines. 1 September 2020, 7 (9): 55. PMC 7554886 . PMID 32882898. doi:10.3390/medicines7090055 .
- ^ Schlicker, Eberhard; Kathmann, Markus. Role of the Histamine H3 Receptor in the Central Nervous System. Histamine and Histamine Receptors in Health and Disease. Springer International Publishing. 2017: 277–299. ISBN 978-3-319-58194-1 （英语）.
- ^ 190.0 190.1 Lapin, Izyaslav. Phenibut (β-Phenyl-GABA): A Tranquilizer and Nootropic Drug. CNS Drug Reviews. 7 June 2006, 7 (4): 471–481. PMC 6494145 . PMID 11830761. doi:10.1111/j.1527-3458.2001.tb00211.x （英语）.
- ^ Kupats, Einars; Vrublevska, Jelena; Zvejniece, Baiba; Vavers, Edijs; Stelfa, Gundega; Zvejniece, Liga; Dambrova, Maija. Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports. Pharmacopsychiatry. September 2020, 53 (5): 201–208. ISSN 0176-3679. PMID 32340063. S2CID 216593771. doi:10.1055/a-1151-5017 （英语）.
- ^ Jędrejko, Karol; Lazur, Jan; Muszyńska, Bożena. Risk Associated with the Use of Selected Ingredients in Food Supplements. Chemistry & Biodiversity. February 2021, 18 (2): e2000686. ISSN 1612-1872. PMID 33410585. S2CID 230821273. doi:10.1002/cbdv.202000686 （英语）.
- ^ Batalla, Albert; Bos, Julian; Postma, Amber; Bossong, Matthijs G. The Impact of Cannabidiol on Human Brain Function: A Systematic Review. Frontiers in Pharmacology. 2021, 11: 618184. ISSN 1663-9812. PMC 7858248 . PMID 33551817. doi:10.3389/fphar.2020.618184 .
- ^ Colizzi, Marco; Ruggeri, Mirella; Bhattacharyya, Sagnik. Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition. Frontiers in Psychology. 2020, 11: 833. ISSN 1664-1078. PMC 7247841 . PMID 32528345. doi:10.3389/fpsyg.2020.00833 .
- ^ Daubner, Johanna; Arshaad, Muhammad Imran; Henseler, Christina; Hescheler, Jürgen; Ehninger, Dan; Broich, Karl; Rawashdeh, Oliver; Papazoglou, Anna; Weiergräber, Marco. Pharmacological Neuroenhancement: Current Aspects of Categorization、 Epidemiology、 Pharmacology、 Drug Development、 Ethics、 and Future Perspectives. Neural Plasticity. 13 January 2021, 2021: e8823383. ISSN 2090-5904. PMC 7817276 . PMID 33519929. doi:10.1155/2021/8823383 （英语）.
- ^ Zajdel, P; Bednarski, M; Sapa, J; Nowak, G. Ergotamine and nicergoline – facts and myths.. Pharmacol Rep. 2015, 67 (2): 360–363. PMID 25712664. S2CID 22768662. doi:10.1016/j.pharep.2014.10.010.
- ^ 197.0 197.1 197.2 Gerbarg, Patricia L.; Brown, Richard P. Phytomedicines for Prevention and Treatment of Mental Health Disorders. Psychiatric Clinics of North America. March 2013, 36 (1): 37–47. PMID 23538075. doi:10.1016/j.psc.2012.12.004.
- ^ Clayton, Paul; Hill, Mariko; Bogoda, Nathasha; Subah, Silma; Venkatesh, Ruchitha. Palmitoylethanolamide: A Natural Compound for Health Management. International Journal of Molecular Sciences. January 2021, 22 (10): 5305. ISSN 1422-0067. PMC 8157570 . PMID 34069940. doi:10.3390/ijms22105305 （英语）.
- ^ Singh, Alok; Purohit, Vinay. A critical review of pyritinol. Drugs & Therapy Perspectives. 1 June 2019, 35 (6): 278–282. ISSN 1179-1977. S2CID 256373631. doi:10.1007/s40267-019-00623-x （英语）.
- ^ 200.0 200.1 200.2 200.3 Zimerman, Maximo; Nitsch, M; Giraux, P; Gerloff, C; Cohen, LG; Hummel, FC. Neuroenhancement of the Aging Brain: Restoring Skill Acquisition in Old Subjects. Annals of Neurology. 2013, 73 (1): 10–15. PMC 4880032 . PMID 23225625. doi:10.1002/ana.23761.
- ^ 201.0 201.1 201.2 Meinzer, Marcus; Antonenko, D; Lindenberg, R; Hetzer, S; Ulm, L; Avirame, K; Flaisch, T; Flöel, A. Electrical brain stimulation improves cognitive performance by modulating functional connectivity and task-specific activation. The Journal of Neuroscience. 2012, 32 (5): 1859–1866. PMC 6703352 . PMID 22302824. doi:10.1523/JNEUROSCI.4812-11.2012.
- ^ Grover, Shrey; Wen, Wen; Viswanathan, Vighnesh; Gill, Christopher T.; Reinhart, Robert M. G. Long-lasting, dissociable improvements in working memory and long-term memory in older adults with repetitive neuromodulation. Nature Neuroscience. September 2022, 25 (9): 1237–1246. ISSN 1546-1726. PMC 10068908 . PMID 35995877. S2CID 251742309. doi:10.1038/s41593-022-01132-3 （英语）.
- News article about the study: LaMotte, Sandee. Brain stimulation improves short-term memory in older adults, study finds. CNN. [15 September 2022]. （原始内容存档于2023-04-08）.
- ^ 203.0 203.1 203.2 203.3 Kupsch, Andreas; Benecke, Reiner; Müller, Jörg; Trottenberg, Thomas; Schneider, Gerd-Helge; Poewe, Werner; Eisner, Wilhelm; Wolters, Alexander; Müller, Jan-Uwe; Deuschl, Günther; Pinsker, Marcus O.; Skogseid, Inger Marie; Roeste, Geir Ketil; Vollmer-Haase, Juliane; Brentrup, Angela; Krause, Martin; Tronnier, Volker; Schnitzler, Alfons; Voges, Jürgen; Nikkhah, Guido; Vesper, Jan; Naumann, Markus; Volkmann, Jens; Deep-Brain Stimulation for Dystonia Study Group. Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia. New England Journal of Medicine. 2006, 355 (19): 1978–1990. PMID 17093249. doi:10.1056/NEJMoa063618.
- ^ Notbohm, Annika; Kurths, Jürgen; Herrmann, Christoph S. Modification of Brain Oscillations via Rhythmic Light Stimulation Provides Evidence for Entrainment but Not for Superposition of Event-Related Responses. Frontiers in Human Neuroscience. 2016, 10: 10. ISSN 1662-5161. PMC 4737907 . PMID 26869898. doi:10.3389/fnhum.2016.00010 .
- ^ Ding, Nai; Simon, Jonathan Z. Cortical entrainment to continuous speech: functional roles and interpretations. Frontiers in Human Neuroscience. 2014, 8: 311. ISSN 1662-5161. PMC 4036061 . PMID 24904354. doi:10.3389/fnhum.2014.00311 .
- ^ Thaut, Michael H., Altenmüller, Eckart; Finger, Stanley; Boller, François , 编, Chapter 13 - The discovery of human auditory–motor entrainment and its role in the development of neurologic music therapy, Progress in Brain Research, Music, Neurology, and Neuroscience: Evolution, the Musical Brain, Medical Conditions, and Therapies (Elsevier), 2015-01-01, 217: 253–266 [2021-12-01], ISBN 9780444635518, PMID 25725919, doi:10.1016/bs.pbr.2014.11.030, （原始内容存档于2017-07-28） （英语）
- ^ Cantor, David S.; Evans, James R. Clinical Neurotherapy: Application of Techniques for Treatment. Academic Press. 2013-10-18. ISBN 9780123972910.
- ^ Diep, Charmaine; Ftouni, Suzanne; Manousakis, Jessica E; Nicholas, Christian L; Drummond, Sean P A; Anderson, Clare. Acoustic slow wave sleep enhancement via a novel, automated device improves executive function in middle-aged men. Sleep. 2019-11-06, 43 (1). ISSN 0161-8105. PMID 31691831. doi:10.1093/sleep/zsz197 .
- ^ Michael, Elizabeth; Covarrubias, Lorena Santamaria; Leong, Victoria; Kourtzi, Zoe. Learning at your brain's rhythm: individualized entrainment boosts learning for perceptual decisions. Cerebral Cortex. 9 November 2022, 33 (9): 5382–5394. PMC 10152088 . PMID 36352510. doi:10.1093/cercor/bhac426 .
- News article about the study: Brain-frequency primer accelerates learning and retention. New Atlas. 1 February 2023 [15 February 2023]. （原始内容存档于15 February 2023）.
- ^ Dündar-Coecke, Selma. Future avenues for education and neuroenhancement. New Ideas in Psychology. 1 December 2021, 63: 100875 [2023-08-16]. ISSN 0732-118X. S2CID 236312270. doi:10.1016/j.newideapsych.2021.100875. （原始内容存档于2023-04-22） （英语）.
- ^ Voinea, Cristina; Vică, Constantin; Mihailov, Emilian; Savulescu, Julian. The Internet as Cognitive Enhancement. Science and Engineering Ethics (Springer Science and Business Media LLC). 2020-04-06, 26 (4): 2345–2362. ISSN 1353-3452. doi:10.1007/s11948-020-00210-8.
- ^ Naeem, Noor-i-Kiran; Yusoff, Muhamad Saiful Bahri; Hadie, Siti Nurma Hanim; Ismail, Irwan Mahazir; Iqbal, Haris. Understanding the Functional Components of Technology-Enhanced Learning Environment in Medical Education: A Scoping Review. Medical Science Educator. 28 February 2023, 33 (2): 595–609. ISSN 2156-8650. PMC 9972326 . PMID 37251205. S2CID 257254561. doi:10.1007/s40670-023-01747-6 （英语）.
- ^ 213.0 213.1 213.2 Drigas, Athanasios; Karyotaki, Maria. Learning Tools and Applications for Cognitive Improvement. International Journal of Engineering Pedagogy (IJEP). 12 June 2014, 4 (3): 71. doi:10.3991/ijep.v4i3.3665.
- ^ Ortiz-Ospina, Esteban; Giattino, Charlie; Roser, Max. Time Use. Our World in Data. 29 November 2020 [11 March 2023].
- ^ 215.0 215.1 Vedechkina, Maria; Borgonovi, Francesca. A Review of Evidence on the Role of Digital Technology in Shaping Attention and Cognitive Control in Children. Frontiers in Psychology. 2021, 12: 611155. ISSN 1664-1078. PMC 7943608 . PMID 33716873. doi:10.3389/fpsyg.2021.611155 .
- ^ Hutchinson, Amanda D.; Wilson, Carlene. Improving nutrition and physical activity in the workplace: a meta-analysis of intervention studies. Health Promotion International. 6 July 2011, 27 (2): 238–249. ISSN 1460-2245. PMID 21733915. doi:10.1093/heapro/dar035.
- ^ Gashaj, Venera; Dapp, Laura C.; Trninic, Dragan; Roebers, Claudia M. The effect of video games, exergames and board games on executive functions in kindergarten and 2nd grade: An explorative longitudinal study. Trends in Neuroscience and Education. 1 December 2021, 25: 100162. ISSN 2211-9493. PMID 34844694. S2CID 237631258. doi:10.1016/j.tine.2021.100162 （英语）.
- ^ Caton, Amy; Bradshaw-Ward, Danita; Kinshuk, Kinshuk; Savenye, Wilhelmina. Future Directions for Digital Literacy Fluency using Cognitive Flexibility Research: A Review of Selected Digital Literacy Paradigms and Theoretical Frameworks. Journal of Learning for Development. 21 November 2022, 9 (3): 381–393 [2023-08-16]. ISSN 2311-1550. S2CID 254004509. doi:10.56059/jl4d.v9i3.818. （原始内容存档于2023-04-08） （英语）.
- ^ Wang, Feng; Kinzie, Mable B.; McGuire, Patrick; Pan, Edward. Applying Technology to Inquiry-Based Learning in Early Childhood Education. Early Childhood Education Journal. 1 March 2010, 37 (5): 381–389. ISSN 1573-1707. S2CID 143666182. doi:10.1007/s10643-009-0364-6 （英语）.
- ^ García-Pérez, Daniel; de Aldama, Carlos; Aguirre-Camacho, Aldo; González-Cuevas, Gustavo. Critical Thinking Assessment of Internet Inquiry and Argumentation in Text Generation. INTED2021 Proceedings 1. March 2021: 5341–5347. ISBN 978-84-09-27666-0. S2CID 233801659. doi:10.21125/inted.2021.1091.
- ^ Setyowidodo, I; Jatmiko, B; Susantini, E; Handayani, A D; Pramesti, Y S. The role of science project based peer interaction on improving collaborative skills and physical problem solving: a mini review. Journal of Physics: Conference Series. 1 April 2020, 1521 (2): 022032. Bibcode:2020JPhCS1521b2032S. S2CID 219448364. doi:10.1088/1742-6596/1521/2/022032.
- ^ Norman, Geoff. Teaching basic science to optimize transfer. Medical Teacher. 1 January 2009, 31 (9): 807–811. ISSN 0142-159X. PMID 19811185. S2CID 26691454. doi:10.1080/01421590903049814.
- ^ Kalyuga, Slava; Renkl, Alexander; Paas, Fred. Facilitating Flexible Problem Solving: A Cognitive Load Perspective. Educational Psychology Review. 1 June 2010, 22 (2): 175–186. ISSN 1573-336X. S2CID 56420974. doi:10.1007/s10648-010-9132-9 （英语）.
- ^ Edgren, Nora; Dubljević, Veljko. The ubiquuity of the fallacy of composition in cognitive enhancement and in education. Theoretical Medicine and Bioethics. 1 February 2023, 44 (1): 41–56. ISSN 1573-1200. PMID 36273366. S2CID 253081249. doi:10.1007/s11017-022-09595-y （英语）.
- ^ Lee, Yong-Seok; Silva, Alcino J. The molecular and cellular biology of enhanced cognition. Nature Reviews Neuroscience. February 2009, 10 (2): 126–140. ISSN 1471-0048. PMC 2664745 . PMID 19153576. doi:10.1038/nrn2572 （英语）.
- ^ George Church told us why he's listing "superhuman" gene hacks. Futurism. [25 July 2021]. （原始内容存档于2023-09-12）.
- ^ Protective alleles. arep.med.harvard.edu. [25 July 2021]. （原始内容存档于2023-09-12） （英语）.
- ^ Eising, Else; Mirza-Schreiber, Nazanin; de Zeeuw, Eveline L.; Wang, Carol A.; Truong, Dongnhu T.; Allegrini, Andrea G.; Shapland, Chin Yang; Zhu, Gu; Wigg, Karen G.; Gerritse, Margot L.; et al. Genome-wide analyses of individual differences in quantitatively assessed reading- and language-related skills in up to 34,000 people. Proceedings of the National Academy of Sciences. 30 August 2022, 119 (35): e2202764119. Bibcode:2022PNAS..11902764E. ISSN 0027-8424. PMC 9436320 . PMID 35998220. doi:10.1073/pnas.2202764119 （英语）.
- University press release: Massive genome study informs the biology of reading and language. Max Planck Society via medicalxpress.com. [18 September 2022]. （原始内容存档于2022-09-20） （英语）.
- ^ O’Connor, Cliodhna; Nagel, Saskia K. Neuro-Enhancement Practices across the Lifecourse: Exploring the Roles of Relationality and Individualism. Frontiers in Sociology (Frontiers Media SA). 2017-03-02, 2. ISSN 2297-7775. doi:10.3389/fsoc.2017.00001.
- ^ 230.0 230.1 Antal, Andrea; Luber, Bruce; Brem, Anna-Katharine; Bikson, Marom; Brunoni, Andre R.; Cohen Kadosh, Roi; Dubljević, Veljko; Fecteau, Shirley; Ferreri, Florinda; Flöel, Agnes; Hallett, Mark; Hamilton, Roy H.; Herrmann, Christoph S.; Lavidor, Michal; Loo, Collen; Lustenberger, Caroline; Machado, Sergio; Miniussi, Carlo; Moliadze, Vera; Nitsche, Michael A; Rossi, Simone; Rossini, Paolo M.; Santarnecchi, Emiliano; Seeck, Margitta; Thut, Gregor; Turi, Zsolt; Ugawa, Yoshikazu; Venkatasubramanian, Ganesan; Wenderoth, Nicole; Wexler, Anna; Ziemann, Ulf; Paulus, Walter. Non-invasive brain stimulation and neuroenhancement. Clinical Neurophysiology Practice. 1 January 2022, 7: 146–165. ISSN 2467-981X. PMC 9207555 . PMID 35734582. doi:10.1016/j.cnp.2022.05.002 （英语）.
- ^ Garmany, Armin; Yamada, Satsuki; Terzic, Andre. Longevity leap: mind the healthspan gap. npj Regenerative Medicine. 23 September 2021, 6 (1): 57. ISSN 2057-3995. PMC 8460831 . PMID 34556664. doi:10.1038/s41536-021-00169-5 （英语）.
- Non-profit hospital press release: Buckles, Susan. A regenerative reset for aging » Center for Regenerative Biotherapeutics. Mayo Clinic. [1 March 2023].
- ^ "nootropic"[Title/Abstract] OR "smart drug"[Title/Abstract] OR "smart drugs"[Title/Abstract] OR "nootropics"[Title/Abstract] OR "cognitive enhancer"[Title/Abstract] - Search Results - PubMed. PubMed. [20 March 2023] （英语）.
- ^ 233.00 233.01 233.02 233.03 233.04 233.05 233.06 233.07 233.08 233.09 Lucke, Jayne C.; Bell, Stephanie K.; Patridge, Bradley J.; Hall, Wayne D. Academic Doping or Viagra for the brain?. EMBO Rep. 2011, 12 (3): 197–201. PMC 3059919 . PMID 21311560. doi:10.1038/embor.2011.15.
- ^ 234.0 234.1 Schuijer, Jantien W.; de Jong, Irja M.; Kupper, Frank; van Atteveldt, Nienke M. Transcranial Electrical Stimulation to Enhance Cognitive Performance of Healthy Minors: A Complex Governance Challenge. Frontiers in Human Neuroscience. 2017, 11: 142. ISSN 1662-5161. PMC 5366312 . PMID 28396631. doi:10.3389/fnhum.2017.00142 .
- ^ The Ethics and Challenges Surrounding Neuroenhancement. NC State News. 8 May 2019 [19 March 2023]. （原始内容存档于2023-04-08）.
- ^ Doctor's Op-Ed: Consumers are losing trust in the supplements industry. Here's why we need to earn it back.. Nutritional Outlook. September 2021 [24 April 2022]. （原始内容存档于2023-06-10） （英语）.
- ^ Prohibited, unlisted, even dangerous ingredients turn up in dietary supplements. Washington Post. [24 April 2022]. （原始内容存档于2021-09-23）.
- ^ Eisenstein, Michael. Setting Standards for Supplements. Scientific American. [19 March 2023]. （原始内容存档于2023-08-06） （英语）.
- ^ Glisson, James K. Dietary Supplements: Safety Issues and Quality Control. Archives of Internal Medicine. 14 March 2011, 171 (5): 476–7; author reply 477. PMID 21403052. doi:10.1001/archinternmed.2011.53.
- ^ 240.0 240.1 Long, Chiau Soon; Kumaran, Harshily; Goh, Khang Wen; Bakrin, Faizah Safina; Ming, Long Chiau; Rehman, Inayat Ur; Dhaliwal, Jagjit Singh; Hadi, Muhammad Abdul; Sim, Yee Wai; Tan, Ching Siang. Online Pharmacies Selling Prescription Drugs: Systematic Review. Pharmacy. April 2022, 10 (2): 42. ISSN 2226-4787. PMC 9031186 . PMID 35448701. doi:10.3390/pharmacy10020042 （英语）.
- ^ Are Dietary Supplements Safe?. www.cancer.org. [19 March 2023]. （原始内容存档于2023-04-08） （英语）.
- ^ El Azab, Noha F.; Abdelaal, Sarah H.; Hassan, Said A.; El-Kosasy, Amira M. Dietary supplement mislabelling: case study on selected slimming products by developing a green isocratic HPLC method for their quality control. Scientific Reports. 24 December 2022, 12 (1): 22305. Bibcode:2022NatSR..1222305E. ISSN 2045-2322. PMC 9790016 . PMID 36566240. doi:10.1038/s41598-022-24830-1 （英语）.
- ^ Grohn, Kristopher J.; Moyer, Brandon S.; Wortel, Danique C.; Fisher, Cheyanne M.; Lumen, Ellie; Bianchi, Anthony H.; Kelly, Kathleen; Campbell, Paul S.; Hagrman, Douglas E.; Bagg, Roger G.; Clement, James; Wolfe, Aaron J.; Basso, Andrea; Nicoletti, Cristina; Lai, Giovanni; Provinciali, Mauro; Malavolta, Marco; Moody, Kelsey J. C60 in olive oil causes light-dependent toxicity and does not extend lifespan in mice. GeroScience. 1 April 2021, 43 (2): 579–591. ISSN 2509-2723. PMC 8110650 . PMID 33123847. S2CID 226206079. doi:10.1007/s11357-020-00292-z （英语）.
- ^ Clausen, Angela; Schlueter, Kirsten. Motives for Using Food Supplements by Otherwise Healthy Adults: Historic and Current Perspectives with Special Focus on Germany. Health Behavior and Policy Review. 1 March 2017, 4 (2): 129–141. doi:10.14485/HBPR.4.2.4.
- ^ Sattler, S., Sauer, C., Mehlkop, G., Graeff, P. The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLOS ONE. 2013, 8 (7): e68821. Bibcode:2013PLoSO...868821S. PMC 3714277 . PMID 23874778. doi:10.1371/journal.pone.0068821 .
- ^ 246.0 246.1 Sattler, S., Forlini, C., Racine, E., Sauer, C. Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement. PLOS ONE. 2013, 8 (8): e71452. Bibcode:2013PLoSO...871452S. PMC 3733969 . PMID 23940757. doi:10.1371/journal.pone.0071452 .
- ^ 247.0 247.1 247.2 Wiegel C., Sattler S., Göritz A. S. Work-related stress and cognitive enhancement among university teachers. Anxiety, Stress & Coping. 2015, 29 (1): 1–18. PMID 25747817. S2CID 22273733. doi:10.1080/10615806.2015.1025764.
- ^ Anomaly, Jonathan; Gyngell, Christopher; Savulescu, Julian. Great minds think different: Preserving cognitive diversity in an age of gene editing. Bioethics. January 2020, 34 (1): 81–89. ISSN 0269-9702. PMC 6973122 . PMID 30941781. doi:10.1111/bioe.12585 （英语）.
- ^ Gyngell, Chris; Easteal, Simon. Cognitive Diversity and Moral Enhancement. Cambridge Quarterly of Healthcare Ethics. January 2015, 24 (1): 66–74. ISSN 0963-1801. PMID 25473859. doi:10.1017/S0963180114000310 （英语）.
- ^ Veit, Walter. Cognitive Enhancement and the Threat of Inequality. Journal of Cognitive Enhancement. 1 December 2018, 2 (4): 404–410. ISSN 2509-3304. S2CID 256624542. doi:10.1007/s41465-018-0108-x （英语）.
- ^ Hernandez, Joe. Billionaire Mark Cuban launches online pharmacy aimed at lowering generic drug prices. [20 March 2023]. （原始内容存档于2022-06-25）.
- ^ Online Pharmacies Can Help You Save Big on Prescription Drugs - Consumer Reports. 18 February 2023 [20 March 2023]. （原始内容存档于2023-02-18）.
- ^ Flower, R. The Osler Lecture 2012 'Pharmacology 2.0, medicines, drugs and human enhancement'. QJM. 1 September 2012, 105 (9): 823–830. PMID 22723455. doi:10.1093/qjmed/hcs105.
- ^ Leary, Timothy. The politics of ecstasy. Berkeley, CA: Ronin Publ. 1998: p.95. ISBN 978-1-57951-031-2.
- ^ Boire, Part I
- ^ Boire, Richard Glen. On Cognitive Liberty Part II. Journal of Cognitive Liberties. 2000, 1 (2) [2015-05-16]. （原始内容存档于2017-02-10）.
- ^ Keeping Freedom in Mind. Center for Cognitive Liberty and Ethics. [3 May 2014]. （原始内容存档于24 April 2018）.
- ^ Blitz, 1058-1060
- ^ 259.0 259.1 Sententia (2013), 356
- ^ Sententia (2013), 355-6
- ^ 261.0 261.1 Ienca, Marcello; Andorno, Roberto. Towards new human rights in the age of neuroscience and neurotechnology. Life Sciences, Society and Policy. 26 April 2017, 13 (1): 5. ISSN 2195-7819. PMC 5447561 . PMID 28444626. doi:10.1186/s40504-017-0050-1.
- Explanatory article from one of its authors: Ienca, Marcello. Do We Have a Right to Mental Privacy and Cognitive Liberty?. Scientific American Blog Network. [20 March 2023]. （原始内容存档于2023-04-08） （英语）.
- News article about the study: Four new human rights proposed to protect us from mind reading and brain hacking. New Atlas. 28 April 2017 [20 March 2023]. （原始内容存档于2023-04-08）.
- ^ Bublitz, Christoph. Cognitive Liberty or the International Human Right to Freedom of Thought. Handbook of Neuroethics. Springer Netherlands. 2015: 1309–1333. ISBN 978-94-007-4707-4 （英语）.
- ^ Corbyn, Zoë. Prof Nita Farahany: 'We need a new human right to cognitive liberty'. The Observer. 4 March 2023 [10 March 2023]. （原始内容存档于2023-06-14）.
- ^ Tech that aims to read your mind and probe your memories is already here. MIT Technology Review. [20 March 2023]. （原始内容存档于2023-06-06） （英语）.
- ^ Muñoz, José M. Achieving cognitive liberty The Battle for Your Brain: Defending the Right to Think Freely in the Age of Neurotechnology Nita A. Farahany St. Martin's Press, 2023. 288 pp.. Science. 17 March 2023, 379 (6637): 1097 [20 March 2023]. PMID 36927033. S2CID 257558736. doi:10.1126/science.adf8306. （原始内容存档于2023-03-24） （英语）.
- ^ In the face of neurotechnology advances, Chile passes 'neuro rights' law. techxplore.com. [26 January 2022]. （原始内容存档于2023-06-01） （英语）.
- ^ Zwart H. Limitless as a neuro-pharmaceutical experiment and as a Daseinsanalyse: on the use of fiction in preparatory debates on cognitive enhancement (PDF). Medicine, Health Care and Philosophy. 2014, 17 (1): 29–38 [2023-08-17]. PMID 23585022. S2CID 29893291. doi:10.1007/s11019-013-9481-5. （原始内容 (PDF)存档于2019-05-04）.
- ^ 268.0 268.1 268.2 268.3 Eickenhorst, Patrick; Vitzthum, Karin; Klapp, Burghard F.; Groneberg, David; Mache, Stefanie. Neuroenhancement Among German University Students: Motives, Expectations, and Relationship with Psychoactive Lifestyle Drugs. Journal of Psychoactive Drugs. 2012, 44 (5): 418–427. PMID 23457893. S2CID 6621896. doi:10.1080/02791072.2012.736845.
- ^ 269.0 269.1 Sattler S., Wiegel C. Cognitive test anxiety and cognitive enhancement: the influence of students' worries on their use of performance-enhancing drugs. Substance Use and Misuse. 2013, 48 (3): 220–32. PMID 23302063. S2CID 34698382. doi:10.3109/10826084.2012.751426.
- ^ Sattler S., Sauer C., Mehlkop G., Graeff P. The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLOS ONE. 2013, 8 (7): e68821. Bibcode:2013PLoSO...868821S. PMC 3714277 . PMID 23874778. doi:10.1371/journal.pone.0068821 .
- ^ Sattler S., Schunck R. Associations Between the Big Five Personality Traits and the Non-Medical Use of Prescription Drugs for Cognitive Enhancement. Frontiers in Psychology. 2016, 6: 1971. PMC 4700267 . PMID 26779083. doi:10.3389/fpsyg.2015.01971 .
- ^ Sattler, S., Mehlkop, G., Graeff, P., Sauer, C. Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics. Substance Abuse Treatment, Prevention, and Policy. 2014, 9: 8. PMC 3928621 . PMID 24484640. doi:10.1186/1747-597X-9-8.
扩展阅读
- Blank, Robert H. Cognitive Enhancement: Social and Public Policy Issues. Palgrave Macmillan UK. 5 November 2016. ISBN 978-1-349-84797-6.
- Bostrom, Nick; Sandberg, Anders. Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. Science and Engineering Ethics. 2009, 15 (3): 311–341. PMID 19543814. S2CID 6846531. doi:10.1007/s11948-009-9142-5.
- Veit, Walter. Cognitive Enhancement and the Threat of Inequality. Journal of Cognitive Enhancement. 2018, 2 (4): 404–410. S2CID 158643005. doi:10.1007/s41465-018-0108-x .